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Abstract 
Systematic Reviews of Interventions to Treat and Prevent Obesity 
Aim 
To systematically review lifestyle interventions to treat and prevent obesity in adults, 
children and vulnerable subgroups.  
Methods 
Cochrane methodology and a „best available evidence‟ approach were adopted to 
produce a series of published systematic reviews. 
Results 
Adults: diets alone and with exercise and/or behaviour therapy compared with control 
significantly reduced weight for up to three years (weighted mean difference weight 
change 4 to 13 kg at one year) and prevented weight gain for up to seven years. 
Exercise as an adjunct to diet and also meal replacements may be effective in the 
long-term maintenance of weight loss. 600 kcal/day deficit or low-fat diet; diet and 
exercise with/without behaviour therapy; significantly reduced the risk of hypertension, 
type 2 diabetes and metabolic syndrome compared with control.  
School-children: 39% of school-based interventions significantly improved mean body-
mass index compared with control. Combined diet and physical activity interventions 
were most effective. It is unclear what elements of interventions are consistently 
effective in preventing excessive weight gain. There can be significant prevention of 
weight gain in children from interventions not conceptualized as obesity prevention 
interventions. 
Vulnerable subgroups: lifestyle interventions can prevent excessive weight gain in 
pregnancy and help weight-concerned women stop smoking. Diet and exercise can 
reduce weight in postmenopausal women. There is insufficient evidence to inform how 
interventions need to be modified to meet the needs of pre-school children or ethnic 
minority groups within the UK.  
Conclusions 
This evidence underpins national guidance, informs government policy and influences 
clinical practice. Population-wide recommendations may be effective in preventing a 
population increase in prevalence of obesity only as part of a government strategy that 
includes environmental change and is coupled with targeted interventions to reduce 
the prevalence of obesity caused at least in part by social inequalities. 
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Statement of objectives, sources and assistance 
This thesis puts into context a series of published systematic reviews of obesity 
research. The aim of this body of work is to systematically and comprehensively 
review the evidence for the effectiveness of interventions to prevent and treat obesity 
in adults and children and in subgroups of the population who are at increased risk of 
obesity.  
Following from these aims, this body of work has several key objectives. These are: 
O1 to evaluate the effectiveness of interventions in terms of improving weight 
status, risk factors for disease and disease; 
O2 to identify study characteristics, process indicators and contextual factors that 
may affect the outcomes of interventions; 
O3 to develop methodology to synthesize evidence from different study designs; 
O4 to assess how the evidence has informed national strategies and clinical 
practice. 
 
The candidate confirms that appropriate credit has been given where reference has 
been made to the work of others. 
 
Collaborative work 
The submitted work consists of nine published documents on a series of systematic 
reviews of obesity research produced as part of collaborative group projects. Appendix 
1 contains letters from all co-authors of these published documents which confirm the 
candidate‟s individual level of contribution to the work. The nine published documents 
are contained within the Appendices (Appendices 2 to 10).  
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Executive Summary 
Systematic Reviews of Interventions to Treat and Prevent Obesity 
Introduction 
Obesity is a major threat to public health; the prevalence and severity of overweight is 
increasing exponentially.  Two in three adults and one in three children in the UK are 
overweight, including obese. Obesity significantly contributes to chronic disease, the 
rates of which are rapidly increasing. The last decade has seen the emergence of the 
early onset of type 2 diabetes, stroke and cardiovascular disease that previously had 
only manifested in adults. The future health and cost burden to society and the NHS 
are daunting.  
The dietary and inactivity risk factors for developing obesity are modifiable and thus 
obesity is potentially preventable. Behaviour change to improve diet and increase 
physical activity forms the foundation of any intervention to prevent and treat obesity. 
There is a need to revisit the evidence as a whole; in order to use the best available 
evidence to underpin national centralized guidance and inform a national strategy to 
manage obesity within the UK. 
Aim 
To systematically and comprehensively review lifestyle interventions to treat and 
prevent obesity in adults and children and in subgroups of the population who are at 
increased risk of obesity.  
Objectives  
O1 to  evaluate the effectiveness of interventions in terms of improving weight 
status, risk factors for disease and disease; 
O2 to identify study characteristics, process indicators and contextual factors that 
may affect the outcomes of interventions; 
O3 to develop methodology to synthesize evidence from different study designs; 
O4 to  assess how the evidence has informed national strategies and clinical 
practice. 
Methods 
Systematic review methodology based upon methods of the Cochrane Collaboration, 
plus the development of a „best available evidence‟ approach which involved 
synthesizing different types of data. If sufficient high quality and up-to-date evidence 
was identified for a specific research question then older studies or those using 
weaker study designs were not examined. In the case of limited evidence from high 
quality studies then the „best available‟ evidence was used and graded according to 
quality and relevance to the research question.  
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The submitted work consists of systematic reviews for the NHS Research and 
Development Health Technology Assessment Programme, National Preventative 
Research Initiative, Cochrane Collaboration and the National Institute for Health and 
Clinical Excellence. Also, five peer-reviewed journal publications (Journal of Human 
Nutrition and Dietetics, Menopause International and Obesity Reviews) including a 
short science review for Foresight the Government Office for Science.  
Results 
Currently there is more evidence of benefit from obesity treatment interventions 
compared with prevention interventions, from studies in adults compared with children 
and about short-term intermediary outcomes compared with longer-term clinical 
outcomes. There is very limited evidence from UK-based studies, interventions in pre-
school children, ethnic minority or other vulnerable groups of people living in the UK. 
There is insufficient evidence to inform how interventions need to be modified in order 
to be targeted and tailored to the needs of these vulnerable groups.  
Diets alone and with the addition of exercise and/or behaviour therapy compared with 
control significantly reduced weight in adults for up to three years (WMD weight 
change in the range of 4 to 13 kg at one year) and prevented weight gain in adults for 
up to seven years (WMD weight change in the range of 0.5 to 7 kg at two years).  
Adding drugs, exercise or behaviour therapies to diet significantly reduced weight in 
adults for up to three years (WMD weight change in the range of 1 to 8 kg at one 
year). Adding either exercise or behaviour therapy was effective but both in 
combination did not significantly improve weight loss.  
Adding behaviour therapy to a prevention intervention produced greater weight loss 
compared with adding exercise. However exercise as an adjunct to diet may be better 
in the longer term. Meal replacements may be a useful tool in the long-term 
maintenance of weight loss. 
Compared to control: combinations of a 600 kcal/day deficit or low-fat diet; diet and 
exercise with and without behaviour therapy; significantly reduced the risk of 
hypertension, type 2 diabetes and the metabolic syndrome. Diet and behaviour 
therapy compared to control, significantly reduced the risk of ovarian cancer. 
In the most recent and comprehensive review of school-based interventions for obesity 
prevention, 39% of interventions were effective in significantly improving mean BMI 
compared with control. Interventions which combined diet and physical activity had the 
greatest percentage of effective studies compared with diet alone and physical activity 
alone. It is unclear what elements of interventions are consistently effective in 
preventing excessive weight gain in children. 
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Lifestyle interventions can help prevent excessive weight gain in pregnancy and may 
help to reduce weight retention between pregnancies and prevent overweight in the 
offspring. Weight gain prevention interventions incorporated into smoking cessation 
programmes may help women who are concerned about their weight to stop smoking. 
Diet and exercise can help to reduce weight in post-menopausal women who are at 
increased risk of cardiovascular disease. 
Most studies failed to report effectiveness stratified by demographic characteristics or 
information about process or contextual factors. 
Evidence shows there can be significant weight gain prevention in children from 
interventions not conceptualized as obesity prevention interventions, which is opposite 
to evidence from interventions in adults that appear more successful when specifically 
aimed at weight loss.  
Conclusions 
The evidence contained within this submitted body of work underpins national 
guidance, informs government policy and influences clinical practice. 
A more flexible approach to producing a systematic review is required when the 
purpose of the review is to develop guidance to help clinical practice or to help develop 
an intervention. In addition to effectiveness, public health decision makers require 
evidence of appropriateness, implementation, feasibility, acceptability and 
sustainability and the context of individual behaviour change within the wider 
community and socio-political environment.  
A „best available evidence‟ approach provides the flexibility to include more evidence 
which can be graded in terms of quality and relevance to the research question. 
Combining quantitative and qualitative evidence can add context, provide 
corroboration and increase understanding, particularly with regard to complex public 
health interventions. Modeling future predictions of the potential impact of obesity 
interventions can provide justification to implement public health interventions even 
when the evidence from systematic reviews is limited.   
A comprehensive, coherent and sustainable public healthy obesity prevention strategy 
is beginning to come into force which is underpinned by the best available evidence. 
Whilst both prevention and treatment are necessary to manage obesity; the priority of 
any comprehensive strategy should be prevention by behavioural change; beginning 
at the stage of pre-conception. Population-wide recommendations may be effective in 
preventing a population increase in prevalence of obesity only as part of a government 
strategy that includes environmental change and is coupled with targeted interventions 
to reduce the prevalence of obesity caused at least in part by social inequalities. 
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Chapter 1 
1 Introduction 
1.1 Aims and objectives 
The overarching theme of this body of work is obesity; including the prevention and 
treatment; in adults and children; by diet, physical activity, behavioural and 
pharmacological interventions; from a public health perspective. The method is 
systematic review, including synthesis of quantitative and qualitative research. 
The aim of this body of work is to systematically and comprehensively review the 
evidence for the effectiveness of interventions to prevent and treat obesity in adults and 
children and in subgroups of the population who are at increased risk of obesity.  
Following from these aims, this body of work has several key objectives. These are: 
O1 to evaluate the effectiveness of interventions in terms of improving weight 
status, risk factors for disease and disease; 
O2 to identify study characteristics, process indicators and contextual factors that 
may affect the outcomes of interventions; 
O3 to develop methodology to synthesize evidence from different study designs; 
O4 to assess how the evidence has informed national strategies and clinical 
practice. 
 
1.2 Definition and measurement 
The biological definition of being obese is to be very fat, where weight exceeds optimal 
weight for height by about 30% and excess weight is stored as body-fat1. Obesity is a 
chronic and progressive condition which poses a serious threat to health2. 
Body mass index (BMI) is a measure of weight relative to height and is defined as weight 
(kg) divided by height (m2).  BMI measures the extent of being overweight; cut-off points 
are applied to BMI to classify weight in adults, which are correlated with risk for serious 
disease (table 1).  
The use of BMI to measure weight in children is more complicated compared with adults 
because children are growing and the relationship between BMI and being overweight 
varies by age, height and gender. United Kingdom (UK) growth data from 1990 (derived 
from a representative sample of 37,700 children constructed by combining data from 17 
separate surveys) is used to express BMI as a percentile based on the BMI distribution 
and adjusted for skewness, age and sex.  „Underweight‟ is less than or equal to the 2nd 
percentile; „overweight‟ is greater than or equal to the 85th percentile but less than the 
95th percentile; „obese‟ is greater or equal to the 95th percentile3. 
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Table 1. World Health Organisation (WHO) classification of weight in adults4:  
Classification BMI (kg/m2) Associated health risks 
Underweight  18.5 Low (but risk of other clinical problems increased) 
Normal range 18.5 – 24.9 Average 
Preobese 25.0 – 29.9 Increased 
Obese class I 30.0-34.9 Moderately increased 
Obese class ii 35.0 – 39.9 Severely increased 
Obese class iii 40 or higher Very severely increased 
 
In 1999 the International Obesity Task Force (IOTF) recommended the use of age and 
sex-specific cut-off points for BMI to define being overweight and obese in children. 
Centile curves were developed that were based on data of children‟s growth from six 
different populations and extrapolated from adult BMI cut-off points.  Median BMI is 
13 kg/m2 at birth, 17 kg/m2 at age one, 15.5 kg/m2 at age six and 21 kg/m2 at age 20. The 
centile curves pass through the points of 25kg/m2 and 30kg/m2 at age 185. 
Classification of a child as overweight therefore depends on which reference population 
is used and what points on the distribution are selected for classification. The universal 
approach of the international reference values is initially appealing. However the 
international reference values may not detect real differences in body composition and 
therefore the relationship between body composition and disease that exist within 
populations6.  
The limitations of BMI mainly relate to its accuracy in measuring obesity within 
individuals and its applicability to different subgroups of the population. For example, the 
incidence of obesity is difficult to measure in children as the ratio of weight gain to height 
gain changes during normal growth. In addition, BMI is an indirect measure of body-fat. 
Children with different amounts of body-fat can have similar BMI; for the equivalent BMI, 
girls aged 7 to 17 years have greater amounts of body-fat than boys of the same age7.  
BMI cut-off points may not be applicable to certain ethnic groups due to differences in 
body composition and distribution of body-fat.  BMI is not an equivalent measure of 
percentage body-fat in different race-sex groups; for the equivalent BMI, white children 
aged 7-17 years have more body-fat than black children7. British South Asian 
adolescents aged 14-17 years have significantly more body-fat than white European 
adolescents, with more central fat8. 
The distribution of body-fat is associated with risk-factors for disease; abdominal fat in 
adults is particularly associated with risk factors for cardiovascular disease (CVD). 
Multiple measures of body-fat such as BMI and waist circumference can provide a more 
accurate prediction of disease risk in individuals and certain subgroups9; however BMI is 
a useful measure to assess prevalence of obesity from a public health perspective10. 
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1.3 Prevalence  
Obesity is a global threat to public health and the most significant public health issue in 
the UK; which has experienced a dramatic increase in both the prevalence and severity 
of overweight. In 1980, rates of obesity in England were 6% in men and 8% in women11; 
the latest trends show that 24% of adults are obese. Rates of being overweight amongst 
English children aged 7-11 years are four times higher than 30 years ago. In England, 
16.5% of children (aged 2-15 years) are obese. An additional 41% of men, 32% of 
women and 14% of children are overweight. Mean BMI is 27.1 kg/m2 for men, 26.8 kg/m2 
for women and 18.4 kg/m2 for children12. The rate of obesity increases steadily with age; 
peaks at age 45-54 years and declines from 75 years13. Incidence rates of maternal 
obesity have also increased with approximately 18% of women of childbearing age (16-
44 years) being obese14.  
The National Child Measurement Programme (NCMP) figures for 2007/08 indicate that 
obesity is twice as high in children aged 10-11 years compared with children aged 4-5 
years. Of children aged 4-5 years, 9.6% are obese and an additional 13% are 
overweight; 18.3% of children aged 10-11 years are obese and an additional 14.3% are 
overweight15.  
The increase in prevalence of obesity is reflected across the world and in most age 
groups including the very young. The IOTF estimates that 10% of children aged 5-17 
years are overweight worldwide including 2.3% obese; which equates to 155 million 
overweight school-children worldwide including 30-45 million school-children who are 
obese16. England has one of the highest prevalence rates of obesity amongst the 
Organisation for Economic Cooperation and Development (OECD)17. In 2004 the 
European Union (EU) average for percentage of obesity was 13.4% for adults aged 15 
years and over; England had the second highest rate of 22.7% 13.  
The Foresight report on obesity18 predicts that by 2050, 60% of males and 50% of 
females could be obese.  
 
1.4 Vulnerable groups and life stages 
Specific subgroups of the population are at increased risk of obesity and obesity-related 
diseases. Children of all ethnic groups, with the exception of Chinese, have a higher 
proportion of obesity than white children at ages 4-5 and 10-11 years. „Black or Black 
British‟ children have 26.4% obesity at age 10-11 years compared with 17.3% „White' 
children15. Irish and Black Caribbean men and Black Caribbean, Black African and 
Pakistani women are at increased risk of obesity19. 
The link between socioeconomic status and obesity in the UK is complex and maybe 
associated with the degree of relative social inequality rather than absolute levels of 
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income18. There is a clear relationship between „equivalised household income‟ and 
obesity for women and girls but not men and boys; 19% of women are obese in the 
highest equivalised household income quintile and the percentage rises in each of the 
other four quintiles to 32% obesity in the lowest quintile13. There appears to be a strong 
positive relationship between deprivation (Index of Multiple Deprivation) and prevalence 
of obesity in children, with 64-65% higher prevalence of obesity in the most deprived 
rank compared with the least deprived15.  
People with disability are particularly vulnerable to obesity. Obesity is linked to muscular-
skeletal conditions, mental health disorders and learning difficulties in adults and 
children20. 
Childhood is a crucial life stage for the development of obesity; children with natural 
parents who are obese are at increased risk of being obese themselves and children 
who are obese in childhood are more likely to be obese in adulthood13 21. For children 
aged 5-17 years and between the 85th and 94th percentiles (i.e. overweight); about half 
were found to be obese at age 18-37 years22. There is some evidence that obesity in 
adolescence has a stronger relationship with adult obesity than obesity in younger 
children23.  
Other life stages associated with increased risk of weight gain include smoking 
cessation, pregnancy and menopause24;25.  
 
1.5 Aetiology 
The aetiology of obesity is complex however in simplistic biological terms, weight gain 
occurs due to an imbalance between the amounts of energy (calories) consumed and the 
amount of energy expended through physical activity.  If more calories are consumed 
than the body requires and uses through physical activity, then weight gain will occur.  
The prevalence of obesity has risen rapidly over a relatively short time, suggesting that 
environmental and behavioural factors have played a greater role than genetics in 
causing this rise11.  
It is probable that in the last three or four decades there has been both an increase in the 
intake of more high fat and high calorie foods and an increase in time spent in sedentary 
activities combined with a decrease in physical activity.  At the very least, energy intake 
has not been reduced to compensate for the reduced energy needs caused by current 
low levels of physical activity. 
The evidence regarding any change in energy intake and expenditure is inconsistent, 
mainly because energy intake is underestimated in food intake surveys and physical 
activity is difficult to accurately measure. Prentice and Jebb summarize UK evidence and 
conclude that excessive food intake relative to energy needs has lead to initial weight 
 14  
gain, but most importantly the reduction in physical activity has greatly reduced energy 
needs and lead to the development of obesity26.  
All energy intake comes from food, whereas 20-40% of energy expenditure is through 
modifiable physical activity. A relatively small excess intake of calories will lead to a 
relatively large cumulative weight gain over a long period of time.  An average daily 
increase in net energy intake of 150 calories is enough to explain the rise in obesity 
prevalence in the United States of America (USA) during 1980 to 200027.  
In 2006, 40% of men and 28% of women met the recommendation of at least 30 minutes 
moderate physical activity on at least five days a week. In 2007, 72% of boys and 63% of 
girls met the recommended target of at least 60 minutes daily physical activity. Three out 
of ten adults and two out of ten children consume a recommended five or more daily 
portions of fruit and vegetables. The average fat content of secondary school meals is 
41% despite a recommended target of 35%13.  
Diet and physical activity are integral parts of the energy balance equation and are 
behaviours which can be modified to prevent and reverse excessive weight gain. 
However the energy balance equation needs to be viewed within the context of an 
obesogenic environment with environmental, social and cultural factors influencing what 
children and adults eat and do. 
 
1.6 Clinical implications for health 
The amount and distribution of fat determines the risk of obesity-related diseases and in 
general the more overweight the greater the risk. In 1998, 6% of all deaths in England 
were attributable to obesity11 and obesity is estimated to cause an average of seven 
years reduction in life expectancy28.  
Obesity causes dyslipidaemia, hypertension, impaired glucose tolerance, metabolic and 
hormonal changes, which in turn contribute to cardiovascular disease, cancers (ovary, 
breast, uterus, prostate, colorectal); metabolic and endocrine diseases such as type 2 
diabetes and other chronic disease such as osteoarthritis. In 1998, 36% of cases of 
hypertension, 47% of cases of type 2 diabetes and 15% of cases of angina were 
attributable to obesity11.Women who are obese are nearly 13 times more likely to have 
type 2 diabetes compared with women who are normal weight13. Maternal obesity 
increases the risk of caesarean and instrumental delivery, haemorrhage and infection14. 
Obesity can exacerbate changes to the lipoprotein profile experienced during 
menopause, which are associated with increased risk of CVD29. 
Alarmingly, during the last decade, obesity-related disease has been identified in 
children.  Unlike in the adult population, there is currently a lack of longitudinal data 
linking childhood BMI to childhood health outcomes22. However cross-sectional data 
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shows that there has been an increase in the incidence of risk factors for CVD, type 2 
diabetes and the metabolic syndrome in adolescents30-33; .  Vascular abnormalities, 
increased blood lipids, glucose intolerance and type 2 diabetes, hypertension and 
increases in liver enzymes are more common in children with obesity34. Obesity in 
adolescence is associated with increased overall mortality, CVD and type 2 diabetes in 
adulthood22.  
 
1.7 Cost burden 
As well as the considerable and increasing health burden, the future health cost 
implications of these disease trends for the National Health Service (NHS) are daunting. 
In 1998 the estimated direct cost to the NHS in England of treating obesity was £9.4 
million and £470 million for treating obesity-related diseases which amounted to 1.5% of 
the total NHS expenditure in England11.  In 2002 the estimated direct cost of GP 
consultations, hospital activity and anti-obesity drugs to the NHS in England was £45.8 - 
£49.0 million. The cost of treating obesity-related conditions was estimated at £945 - 
£1,074 million, which was 2.5% of the total NHS expenditure in England. When the cost 
of loss of income attributable to obesity-related illness and death were included the total 
cost to society was estimated at £3.3 - £3.7 billion35. 
In 2007/08, there were over 5000 NHS hospital admissions with a primary diagnosis of 
obesity, almost seven times greater than ten years earlier. In 2007 there were over a 
million prescription items for drugs for the treatment of obesity in England, nearly ten 
times the number prescribed in 199913. The Foresight report on obesity18 predicts that by 
2050 the annual NHS cost of obesity and its consequences could rise from £1 billion to 
£6.5 billion.  
 
1.8 Public health perspective 
The overarching goals of public health are to improve the health of the population and 
reduce inequalities in health outcomes. These two goals are inter-dependent because 
increasing health inequalities affects the overall health of the whole population36. 
The degree of relative social inequality and risk of obesity are inextricably linked and the 
obesity epidemic is contributing significantly to the wider socioeconomic inequalities in 
health. Obesity interventions targeted and tailored to individuals with the highest risk of 
obesity will help to reduce the prevalence of obesity (caused at least in part by social 
inequalities) and may help to reduce inequalities in health, but only as part of a national 
strategy to tackle the underlying social, economic and environmental determinants of 
health.  
 16  
Evidence from obesity interventions needs to be viewed within the context of an 
obesogenic environment. Behaviour change in terms of eating healthier and exercising 
more is influenced by economic, environmental and social factors which are often 
beyond the control of the individual. 
From a public health perspective; both prevention and treatment interventions are 
necessary to manage obesity; however, the priority of any comprehensive strategy 
should be prevention which begins at the stage of pre-conception. Focusing solely on 
treatment of obesity is insufficient to reduce the prevalence, because as people with 
obesity are being treated, other people are becoming obese. Treatments to reduce 
obesity will only ever provide a partial solution. It is preferable for children and adults to 
attain and remain a normal weight, rather than require treatment for being overweight.  
Prevention of obesity in childhood will reduce the prevalence of adult overweight and 
associated diseases. Children may also be more amenable to change in dietary and 
activity habits since their lifestyle habits are still developing.  
Interventions to improve diet and increase physical activity are indispensable elements of 
any intervention for the treatment and prevention of obesity. Changing behaviour to 
improve public health has the potential for the greatest benefit to health yet is probably 
the most challenging type of intervention. 
 
1.9 Summary 
Obesity is a major threat to public health; the prevalence and severity of overweight is 
increasing exponentially.  Two in three adults and one in three children in the UK are 
overweight including obese. Obesity significantly contributes to chronic disease, the rates 
of which are rapidly increasing. The last decade has seen the emergence of the early 
onset of type 2 diabetes, stroke and CVD that previously had only manifested in adults. 
The future health and cost burden to society and the NHS are daunting.  
The dietary and inactivity risk factors for developing obesity are modifiable and thus 
obesity is potentially preventable. Behaviour change relating to diet and physical activity 
must form the foundation of any intervention to prevent and treat obesity; however 
behaviour change interventions need to appreciate the influence of the obesogenic 
environment.  
From a public health perspective, BMI adequately measures the prevalence of obesity 
and is a useful tool to measure the effectiveness of interventions to prevent or treat 
obesity. Interventions may need to be targeted at vulnerable groups such as children and 
adults of lower socioeconomic status and ethnic minorities; and during vulnerable life 
stages such as when stopping smoking, being pregnant and experiencing the 
menopause.  
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There is great potential for health improvement in terms of improved quality of life, 
increased life expectancy, and cost savings that could be directed towards other 
healthcare needs. 
  
1.10 Structure and outline of the submitted work  
1.10.1 The submitted work 
The submitted work provides a comprehensive and systematic review of the evidence of 
lifestyle interventions to prevent and treat obesity within the whole population and within 
particularly vulnerable groups. 
When this body of work was initiated there was a clear and urgent need for national 
centralized guidance for the management of obesity, based on the best available 
evidence. Unlike other chronic diseases, there was no integrated system within the NHS 
for managing obesity and obesity was only managed clinically in the presence of obesity-
related co-morbidities11. As the issue of obesity came to dominate public health; this 
body of work intended to inform the issue of obesity and provide future direction for 
public health decision making with regard to a comprehensive obesity strategy within the 
UK. During the development of this body of work, the National Institute for Health and 
Clinical Excellence (NICE) commissioned reviews of the evidence of interventions to 
manage obesity24, including reviews contained within this research, in order to develop 
national guidelines on the prevention and management of obesity that were published in 
200737.  
In the last decade there have been numerous systematic reviews assessing the 
effectiveness of interventions to manage obesity. These reviews have applied different 
inclusion criteria which varied with regard to study design, setting, duration, definition of 
excess weight and the types of outcomes reported, making it difficult to summarize the 
evidence. There is a need to revisit the evidence as a whole and to use the best 
available evidence; which is the premise underpinning this body of work. 
Seven systematic reviews were produced in the following format; a report for the NHS 
Research and Development Health Technology Assessment (HTA) Programme38; a 
report for the National Prevention Research Initiative (NPRI)39; a systematic review for 
the Cochrane Collaboration40; three reviews for NICE24 and a review personally 
requested by the editor of the Menopause International journal41. Other outputs from 
these systematic reviews are four publications in peer-reviewed journals42;43; including an 
update of the NICE review of school-based interventions44 and a short science review for 
Foresight the Government Office for Science45.  
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The following is a reference list of the papers which form the submitted work, the order of 
which mirrors the presentation in chapter 2: 
Systematic reviews of the treatment and prevention of obesity in adults  
Treatment 
HTA Report 
Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WCS, Jung RT, 
Campbell MK, Grant AM. Systematic review of the long-term effects and economic 
consequences of treatments for obesity and implications for health improvement.  Health 
Technol Assess 2004; 8 (21):1-458. http://www.hta.ac.uk/1187 (Appendix 2) 
Linked publications 
Avenell A, Brown TJ, McGee MA, Campbell MK, Grant AM, Broom J, Jung RT, Smith 
WCS. What interventions should we add to weight reducing diets in adults with obesity? 
A systematic review of randomised controlled trials of adding drug therapy, exercise, 
behaviour therapy or combinations of these interventions. Journal of Human Nutrition 
and Dietetics 2004; 17(4): 293-316. (Appendix 3) 
Avenell A, Brown TJ, McGee MA, Campbell MK, Grant AM, Broom J, Jung RT, Smith 
WCS. What are the long-term benefits of weight reducing diets in adults? A systematic 
review of randomised controlled trials. Journal of Human Nutrition and Dietetics 2004; 17 
(4): 317-335. (Appendix 4) 
Prevention 
NPRI Review 
Brown T, Avenell A, Edmunds LD, Moore H, Whittaker V, Avery L and Summerbell C for 
the PROGRESS team. Systematic Review of Long-term Lifestyle Interventions to 
Prevent Weight Gain and Morbidity in Adults. Obesity Reviews 2009; 10(6):627-38. Epub 
2009 Sep 14. DOI: 10.1111/j.1467-789X.2009.00641.x (Appendix 5) 
Systematic reviews of the prevention of obesity in children 
Cochrane Review 
Summerbell CD, Waters E, Edmunds LD, Kelly S, Brown T, Campbell KJ. Interventions 
for Preventing Obesity in Children. The Cochrane Database of Systematic Reviews 
2005, Issue 3. Art. No.: CD001871.pub2. DOI: 10.1002/14651858.CD001871.pub2. 
(Appendix 6)  
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NICE Guideline 
National Institute for Health and Clinical Excellence. Obesity: The Prevention, 
Identification, Assessment and Management of Overweight and Obesity in Adults and 
Children. Clinical guideline. CG43 Obesity; full guideline, section 3- prevention: evidence 
statements and reviews. National Institute for Health and Clinical Excellence, 2006.  
http://www.nice.org.uk/guidance/CG43. (Appendix 7) 
Specifically;  
8. Prevention evidence summary: interventions for pre-school children and family-
based interventions („early years‟), p287-295.  
9. Prevention evidence summary: school-based interventions, p296-316. 
Linked publications 
Brown T, Kelly S, Summerbell C. Prevention of obesity: a review of interventions. Short 
Science Review. Foresight Tackling Obesities: Future Choices. Obesity Reviews 2007; 8 
(Suppl 1): 127-130. http://www.foresight.gov.uk. (Appendix 8) 
T. Brown and C. Summerbell. Systematic review of school-based interventions that focus 
on changing dietary intake and physical activity levels to prevent childhood obesity: An 
update to the obesity guidance produced by the National Institute for Health and Clinical 
Excellence. Obesity Reviews 2009; 10: 110-141. (Appendix 9) 
Systematic reviews of obesity interventions targeted at black, minority ethnic 
groups, vulnerable groups and individuals at vulnerable life-stages 
NICE Guideline 
National Institute for Health and Clinical Excellence. Obesity: The Prevention, 
Identification, Assessment and Management of Overweight and Obesity in Adults and 
Children. Clinical guideline. CG43 Obesity; full guideline, section 3- prevention: evidence 
statements and reviews. National Institute for Health and Clinical Excellence, 2006.  
http://www.nice.org.uk/guidance/CG43. (Appendix 7) 
Specifically;  
13. Prevention evidence summary: interventions aimed at black, minority ethnic 
groups, vulnerable groups and vulnerable life stages („BMEGs‟), 365-390.  
Invited publication 
Brown Tamara J. Health benefits of weight reduction in postmenopausal women: a 
systematic review. Menopause International 2006;12(4): 164-171. (Appendix 10) 
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1.10.2 Relationship between the submitted reviews 
As well as evaluating the effectiveness of interventions, systematic reviews can provide 
an overview of the evidence in context and highlight any gaps in research where 
evidence is limited which can stimulate further research. The reviews included in this 
submission are linked by the research recommendations made in response to the gaps 
in the evidence highlighted by each antecedent review.  
In 2000 the HTA programme commissioned the „Systematic Review of Long-Term 
Effects and Economic Consequences of Treatments for Obesity and Implications for 
Health Improvement‟38 in response to identifying this as a key gap in the evidence 
needed by the NHS. Outputs from the HTA report include two peer-reviewed journal 
articles42;43. The HTA report recommended that a review of prevention interventions be 
carried out and in response the „Systematic Review of Long-Term Lifestyle Interventions 
to Prevent Obesity in Adults‟ was produced39.  
In 2004 NICE commissioned a series of rapid reviews which formed the supporting 
evidence for their Obesity Guidance37. The candidate was responsible for five of these 
rapid reviews including three submitted in this body of work; interventions for pre-school 
children and family-based interventions; school-based interventions; and interventions 
aimed at black, minority ethnic groups, vulnerable groups and vulnerable life stages24.  
The NICE Obesity reviews24 brought together all the evidence accumulated within the 
existing reviews38;40. A short science review was published45 which underpinned the 
evidence gathered for the Foresight report into tackling obesities18. A „Systematic review 
of school-based interventions that focus on changing dietary intake and physical activity 
levels to prevent childhood obesity: an update to the obesity guidance produced by the 
National Institute for Health and Clinical Excellence‟ has since been published44. In 
addition the systematic review: „Interventions for Preventing Obesity in Children‟ was 
updated for the Cochrane Collaboration40.  
The NICE review of cohorts24;25 to assess key determinants of weight gain highlighted 
smoking cessation, pregnancy and menopause as key life-stages associated with 
increased risk of excessive weight gain. In response to these findings, a systematic 
review of health benefits of weight reduction in postmenopausal women41 was 
conducted. A review of interventions targeted at black, minority ethnic groups, vulnerable 
groups and vulnerable life stages was commissioned on behalf of NICE and carried out 
by the candidate24;46.  
The reviews are also linked through systematic review methodology which has 
developed in symbiosis with the obesity research. For example, the NICE obesity 
reviews applied a „best available evidence‟ approach47 which was developed in response 
to the limitations of the evidence gathered within the Cochrane obesity prevention 
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review40. The „best available evidence‟ approach enabled inclusion of lesser quality 
studies, studies not aimed specifically at obesity prevention and studies of shorter 
duration. It also included corroborative evidence to provide information about context and 
process in order to enrich the effectiveness data.  This „best available evidence‟ 
approach has become a prerequisite for systematic reviews which are used to inform 
guidance and practice in public health. 
 
1.10.3 Professional development – a chronology 
In 2001 I began my career as a research assistant on the HTA review38 where I did the 
bulk of the searching, data extraction and meta-analysis by following a pre-set protocol 
and guidance from the lead reviewer. In 2002 I gained an MSc by Research in Public 
Health. Following the completion of the HTA review I co-wrote two papers42;43 and 
undertook consultancy in obesity research whilst I became Research Associate then 
Research Fellow.  
In 2005 I became lead reviewer at the Obesity Collaborating Centre for NICE at the 
University of Teesside where I managed a team to produce five rapid reviews24 and 
presented evidence to the Guideline Development Group (GDG). I also began to focus 
on developing methodology to deal with the increasing complexity of evidence within 
systematic reviews which was required by decision-makers. I was asked by Foresight to 
write a short report45 on the main results from the NICE reviews which were used to 
underpin the Foresight report into tackling obesity18.  
Based on the knowledge gained from producing the NICE reviews of interventions to 
prevent obesity in children24 I became a collaborator on the Cochrane update of 
interventions to prevent obesity in children40 and made significant contributions to the 
protocol and discussion. Following this, I updated the NICE schools review of 
interventions to prevent obesity in school-children and produced a publication as first 
author44. The editor of Menopause International invited me to write a paper on the health 
benefits of weight reduction in postmenopausal women of which I was single author of 
the publication41.  
On the strength of my experience I was asked to produce another large-scale systematic 
review of obesity interventions for the University of Aberdeen as part of the NPRI. I am 
first-author of a paper on this work which has recently been published in Obesity 
Reviews39. 
My experience has led to being invited to act as peer reviewer, speak at conferences, 
contribute to scoping and briefing events and write a book chapter. As well as managing 
review teams I now train students in systematic review methodology. 
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1.10.4 Presentation of the submitted work 
CHAPTER 2 presents both the methods and results for the treatment and prevention of 
obesity in adults; the prevention of obesity in children; and for interventions targeted at 
black, minority ethnic groups, vulnerable groups and individuals at vulnerable life stages.  
CHAPTER 3 discusses and puts into context the results from chapter 2 with particular 
reference to methods of evaluating effectiveness.  
CHAPTER 4 provides the conclusion to this body of work. This chapter summarizes the 
main findings according to the objectives and highlights the contribution of the submitted 
body of work to the overall body of knowledge. 
CHAPTERS 2, 3 & 4 provide interlinking passages between the submitted body of work 
which is presented and discussed as a whole.  
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Chapter 2 
2 Systematic Reviews of Interventions to Treat and 
Prevent Obesity 
2.1 Systematic reviews of treatment and prevention of obesity 
in adults 
2.1.1 Methodology 
Treatment 
The HTA review38;42;43 was underpinned by a pre-specified protocol which was devised 
using the methods of the Cochrane Collaboration48. Study inclusion criteria were; 
randomised controlled trials (RCTs) with a minimum duration of one year; in adults with a 
mean age of at least 18 years and a mean BMI of 28 kg/m2 or greater. Types of included 
interventions were drugs, diets, exercise and behaviour therapy. Drugs used to aid 
weight loss in the UK at the time of the HTA review are detailed in Table 2. Weight loss 
or the prevention of weight gain had to be explicitly stated as a main outcome of the 
study and the primary outcome measure was weight change. 
The search strategy included weight and obesity related terms and text words combined 
with a strategy for identifying RCTs. Thirteen electronic databases were searched and 
specific journals were hand searched. Data extraction was carried out using a form 
generated from the outcomes pre-specified in the review protocol. Quality assessment 
included the quality of random allocation concealment, whether the analysis was based 
on an intention-to-treat and blinding of outcome assessors.  
Where results from studies could be quantitatively combined, a statistical meta-analysis 
of the data was performed to determine the effect size of the intervention. For continuous 
data (such as weight change) a weighted mean difference (WMD) was calculated 
(weighted by the inverse of the variance) and a fixed effects approach was adopted.  If 
data could not be combined quantitatively it was assessed qualitatively. 
Meta-analysis requires a mean and standard deviation of the change between two time-
points; change sometimes needed calculating from actual values. Missing standard 
deviations were imputed by means of linear regression for weight and from the means of 
reported standard deviations in the case of risk factors. 
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Prevention 
The NPRI review39 was based on the methods used in the HTA review38 and the data 
extraction form was adapted according to the NPRI review protocol. Study inclusion 
criteria were; RCTs, with a minimum duration of two years; in adults aged 18 to 65 years 
with BMI less than 35 kg/m2. Types of included interventions were diets, exercise and 
behaviour therapy. The primary outcome measure was weight change and the study did 
not have to be aimed at obesity prevention and could include the prevention of disease 
or improvement of health. 
Interventions were categorised as interventions with definite intention to lose weight and 
interventions with no definite intention to lose weight. Key systematic reviews and eight 
electronic databases were searched for relevant studies and two journals were hand 
searched. 
 
Table 2. Pharmacotherapy used for weight loss when HTA report produced. 
Name of drug Action of drug 
Acarbose (Glucobay® manufactured by 
Bayer) 
Inhibits digestion of starch and sucrose, 
used to improve blood glucose control in 
people with diabetes. 
Metformin  
(Glucophage® manufactured by Lipha; 
Glucamet® manufactured by Opus) 
Decreases release of glucose into the 
circulation, increases glucose uptake into 
the tissues, improves blood glucose 
control in people with diabetes. 
Orlistat  
(Xenical® manufactured by Roche) 
Inhibits all gastrointestinal lipases needed 
to absorb dietary fat. By reducing 
absorption; caloric intake is decreased. 
Sibutramine  
(Reductil® and Meridia® manufactured by 
Abbott) 
Reuptake inhibitor of noradrenaline, 
serotonin and dopamine, reduces food 
intake by producing a feeling of satiety.  
Selective serotonin reuptake inhibitors; 
Fluoxetine (Prozac® manufactured by 
Dista; Felicium® manufactured by Opus) 
Sertraline (Lustral® manufactured by 
Pfizer). 
Inhibits the uptake of serotonin by the 
brain and also inhibit appetite. Primarily 
used to treat depression. 
 
2.1.2 Results 
Eighty-four RCTs assessed the effects of lifestyle and drug treatments for obesity in 
adults with a BMI of 28 kg/m2 or greater, at least one year from randomisation38;42;43. 
Thirty-nine RCTs examined lifestyle interventions to prevent weight gain in adults with a 
BMI less than 35 kg/m
2 at least two years from baseline39. Some studies were included in 
both reviews38;39. 
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Weight 
Treatment 
Intervention versus control 
 
All six comparisons produced significant benefit in terms of weight loss for the 
intervention group (Table 3).  
Table 3. Table of summary estimates for weight changes from RCTs of weight reduction 
- Intervention versus (vs) control ((WMD and 95% confidence interval (CI), in kg)). 
Comparison  
12 
months  
18 
months  
24  
months  
30 
months  
36 
months  
60 
months  
600 kcal/day deficit or 
low-fat diet vs control 
-5.31*  
(-5.86, 
-4.77) 
-1.15  
(-2.76, 
0.45) 
-2.35*  
(-3.56, 
-1.15) 
 -3.55*  
(-4.54, 
-2.55) 
-0.20  
(-2.03, 
1.63)  
LCD vs control  
-6.25* 
(-9.05, 
-3.45)   
 -7.00*  
(-10.99, 
-3.01) 
 -6.10*  
(-10.71, 
-1.49) 
 
VLCD vs control  
-13.40*  
(-18.43, 
-8.37) 
     
Diet and exercise vs 
control  
-4.78* 
(-5.41, 
-4.16) 
 -2.70*  
(-3.60, 
-1.80) 
   
Diet and behaviour 
therapy vs control 
-7.21* 
(-8.68, 
-5.75) 
 -1.80  
(-4.77, 
1.17) 
   
Diet, exercise and 
behaviour therapy vs 
control 
-4.00* 
(-4.46, 
-3.54) 
-3.40*  
(-3.84, 
-2.97) 
-3.00*  
(-3.59, 
-2.40) 
-4.68*  
(-6.08,-
3.28) 
-2.00*  
(-2.66, 
-1.34) 
 
* Significant difference 
 
At 12-months follow-up, WMD weight change ranged from -4.00 kg (95% CI; -4.46,-3.54) 
in the diet, exercise and behaviour therapy intervention versus control, to -13.40 kg (95% 
CI; -18.43,-8.37) in the VLCD intervention versus control. In descending order, the 
greatest WMD weight change was;  
Very low-calorie diet (VLCD) versus control 
Diet and behaviour therapy versus control 
Low-calorie diet (LCD) versus control 
600 kcal/day deficit or low-fat diet versus control  
Diet and exercise versus control  
Diet, exercise and behaviour therapy versus control 
Diet alone can produce similar weight loss to diet in combination with exercise and/or 
behaviour therapy when compared to no-treatment control for up to three years. 
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Adjuncts to diet only, diet and behaviour therapy, diet and exercise 
Three of the five drug adjuncts (Orlistat, Sibutramine, Acarbose) and two of the three 
lifestyle adjuncts (exercise, behaviour therapy) produced significant benefit in terms of 
weight loss for the intervention group at 12 months (Table 4). 
Table 4. Table of summary estimates for weight changes from RCTs of weight reduction 
– adjuncts to diet (WMDs and 95% CI, in kg). 
Comparison  12 months  18 months  24 months  36 months  
60 
months  
Adjuncts to diet      
Orlistat and diet 
vs diet  
-3.01*  
(-3.48,-2.54) 
 -3.26*  
(-4.15,-2.37) 
  
Sibutramine and 
diet vs diet  
-4.12*  
(-4.97,-3.26) 
    
Selective 
serotonin 
reuptake 
inhibitor 
and diet vs diet  
-0.33  
(-1.49,0.82) 
    
Metformin and 
diet vs diet  
-1.09  
(-2.29,0.11) 
 
-0.50  
(-4.02,3.02) 
 -0.12  
(-1.13, 
0.89) 
Acarbose and 
diet vs diet  
-0.79*  
(-1.53,-0.05) 
    
Exercise and 
diet vs diet  
 
-1.95* 
(-3.22,-0.68) 
 
-7.63*  
(-10.33,-4.92) 
 -8.22*  
(-15.27,-
1.16) 
 
Behaviour 
therapy and diet 
vs diet  
 
-7.67* 
(-11.97,-3.36) 
 
-4.18*  
(-8.32,-0.04) 
  
-2.91  
(-8.60,2.78) 
1.90  
(-3.76, 
7.56) 
Exercise and 
behaviour 
therapy and diet 
vs diet 
 
-0.67 
(-4.22,2.88) 
-2.06  
(-5.57,1.45) 
-1.40  
(-5.01,2.21) 
  
Other adjuncts      
Exercise and 
behaviour 
therapy and diet 
vs diet and 
behaviour 
therapy 
 
 
-3.02* 
(-4.94,-1.11) 
 
-2.16*  
(-4.20,-0.l2) 
  
Behaviour 
therapy and 
exercise and 
LCD vs LCD and 
exercise 
-10.69* 
(-14.22,-7.16) 
    
* Significant difference 
 
In terms of adjuncts to diet only, at 12 months follow-up there was significant WMD 
weight change which ranged from -0.79 kg (95% CI; -1.53,-0.05) in the Acarbose and 
diet versus diet only intervention,  to -7.67 kg (95% CI; -11.97,-3.36) in the behaviour 
therapy and diet versus diet alone intervention.  Behaviour therapy added to a low-
calorie diet and exercise combination produced the greatest WMD weight change of -
10.69 kg (95% CI; -14.22,-7.16) at 12 months.  
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In descending order, the greatest WMD weight change was;  
Behaviour therapy and exercise and LCD versus LCD and exercise  
Behaviour therapy and diet versus diet  
Sibutramine and diet versus diet  
Exercise and behaviour therapy and diet versus diet and behaviour therapy  
Orlistat and diet versus diet 
Exercise and diet versus diet  
Acarbose and diet versus diet  
The addition of exercise or behaviour to diet was associated with improved weight loss 
however when adding both exercise and behaviour therapy to diet, weight loss was not 
significantly improved.  
Adding behaviour therapy to a diet (-7.67 kg, 95% CI; -11.97,-3.36) or diet plus exercise 
intervention (-10.69 kg, 95% CI; -14.22,-7.16) produced greater weight loss compared with 
adding exercise to a diet (-1.95 kg, 95% CI; -3.22,-0.68) or diet plus behaviour therapy 
intervention (-3.02 kg, 95% CI; -4.94,-1.11). However exercise as an adjunct to diet may be 
better in the longer term as exercise (-8.22 kg, 95% CI; -15.27, -1.16) but not behaviour 
therapy (-2.91 kg, 95% CI; -8.60, 2.78) demonstrated significant weight loss when added to 
diet at three years. 
 
Head-to-head comparisons 
All comparisons of different types of diet failed to showed any significant difference 
between groups for weight at any time except protein-sparing modified fast (PSMF) 
versus VLCD at 18 months when the VLCD group lost more weight (Table 5).  
 
Table 5. Table of summary estimates for weight changes from RCTs of weight reduction 
– head-to-head comparisons (WMDs and 95% CI, in kg). 
Comparison  12 months  18 months  24 months  36 months  60 months  
LCD vs 600 
kcal/day or low-fat 
diet 
1.63  
(-1.26,4.52) 
    
VLCD vs 600 
kcal/day or low-fat 
diet 
  
-4.70  
(-11.79,2.39) 
  
VLCD vs LCD  
-0.15  
(-2.73,2.43) 
-1.13  
(-5.32,3.06) 
   
PSMF vs LCD  
-3.57  
(-7.36,0.22) 
0.69  
(-1.58,2.96) 
-2.17  
(-4.88,0.54) 
-1.51  
(-5.43,2.41) 
0.20  
(-5.68,6.08) 
PSMF vs VLCD  
 2.73* 
(0.07,5.39) 
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Prevention 
Intervention versus control 
Five of eight comparisons demonstrated significant benefit in terms of weight loss for the 
intervention group in studies that were specifically aimed at weight loss (Table 6).  
Table 6. Table of summary estimates for weight changes from RCTs of weight 
prevention – Intervention vs control (WMDs and 95% CI, in kg). 
Comparison 
24  
months 
30  
months 
36  
months 
48 
months 
54 
months 
72  
months 
90 
months 
Intention to lose weight   
600 kcal/day 
deficit or low-fat 
vs control 
-0.76  
(-2.41, 
0.89) 
 
0.70  
(-1.78, 
3.18) 
 
-3.49* 
(-4.63, 
-2.35) 
    
LCD vs control 
-7.00*  
(-10.99, 
-3.01) 
 -6.10* 
(-10.71, 
-1.49) 
    
Weight Watchers 
vs control 
-2.70*  
(-3.95, 
-1.45) 
      
VLCD + meal 
replacements vs 
low-fat control 
-4.70  
(-11.79, 
2.39) 
      
Behaviour 
therapy 
(telephone) vs 
control 
-0.34  
(-0.95, 
0.27 
      
Behaviour 
therapy (mail) vs 
control 
-0.14  
(-0.75, 
0.47) 
      
Diet and exercise 
vs control 
-2.56*  
(-3.34, 
-1.77) 
      
Diet, exercise 
and behaviour 
therapy vs 
control  
-2.47*  
(-3.18, 
-1.77) 
 -2.04*  
(-2.70, 
-1.39) 
 -2.50*  
(-3.59, 
-1.41) 
  
No intention to lose weight   
Low-fat non-
reducing diet vs 
control 
-1.42*  
(-2.10, 
-0.74) 
      
Behaviour 
therapy vs 
control 
-1.30  
(-2.83, 
0.23) 
      
Diet and 
behaviour 
therapy vs 
control 
-1.01*  
(-1.34, 
-0.68) 
 -1.77*  
(-1.94, 
-1.59) 
-0.52*  
(-0.85, 
-0.19) 
 0.20  
(-0.26, 
0.66) 
-0.70*  
(-0.90, 
-0.50) 
Diet, exercise 
and behaviour 
therapy (clinic) vs 
control 
-1.40  
(-3.12, 
0.32) 
 -0.80  
(-2.35, 
0.75) 
    
Diet, exercise 
and behaviour 
therapy (home) 
vs control 
-1.50  
(-2.20, 
1.20) 
 0.60  
(-1.16, 
2.36) 
    
* Significant difference  
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Two of the five comparisons that were not specifically aimed at weight loss did 
demonstrate significant weight loss for the intervention group although the amount of 
weight loss (WMD weight change 0.5 kg to 2.8 kg) was less than in studies specifically 
aimed at weight loss (WMD weight change 2.0 kg to 7.0 kg). 
At two years follow-up WMD weight change ranged from -1.01 kg (95% CI; -1.34,-0.68) 
in the diet and behaviour therapy versus control intervention to -7.00 kgs (95% CI; -
10.99,-3.01) in the low-calorie diet versus control intervention. In descending order, the 
greatest WMD weight change at 12 months was;  
LCD versus control 
Weight Watchers versus control 
Diet and exercise versus control 
Diet, exercise and behaviour therapy versus control 
Low-fat non-reducing diet versus control 
Diet and behaviour therapy versus control 
Interventions combining diet with additional elements compared to control were not 
always associated with greater weight loss. Both diet and exercise (-2.56 kg, 95% CI; -
3.34,-1.77) and diet, exercise and behaviour therapy (-2.47 kg, 95% CI; -3.18,-1.77) 
versus control produced similar WMD weight change, which was less than some of the 
diets alone versus control. There was no evidence assessing the effectiveness of 
exercise alone compared to control on weight. 
 
Adjuncts to diet 
At two years there was no additional benefit to weight of adding exercise to diet or 
adding exercise plus behaviour therapy to diet (Table 7). Meal replacements in addition 
to diet produced significant improvement in weight at 51 months but not at 27 months. 
Meal replacements in addition to diet combined with exercise and behaviour therapy 
produced significant improvement in weight at 24 months. 
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Table 7. Table of summary estimates for weight changes from RCTs of weight 
prevention – Adjuncts to diet (WMDs and 95% CI, in kg). 
Comparison 
24  
months 
27  
months 
29/33 
months 
51  
months 
Intention to lose weight 
Diet, exercise and behaviour 
therapy vs diet 
-1.40  
(-5.01,2.21) 
   
Diet and meal replacement vs 
diet 
 
-2.70  
(-6.89,1.49) 
 -5.40*  
(-8.97, 
-1.83) 
Diet, exercise, behaviour 
therapy and meal replacement 
vs diet, exercise, behaviour 
therapy 
-6.00*  
(-10.19,-1.81) 
   
Diet, exercise, behaviour 
therapy and food provision vs 
diet, exercise, behaviour 
therapy  
0.55 (-2.96,4.06) 
 
  
Diet, exercise, behaviour 
therapy and financial incentive 
vs diet, exercise and 
behaviour therapy  
1.30 (-2.16,4.76)    
Diet, exercise, behaviour 
therapy, food provision and 
financial incentive vs diet, 
exercise and behaviour 
therapy  
1.30 (-2.16,4.76)    
Diet, exercise, behaviour 
therapy and food provision vs 
diet, exercise, behaviour 
therapy and financial incentive 
-0.75 (-3.85,2.35)    
Diet, exercise, behaviour 
therapy, food provision and 
financial incentive vs diet, 
exercise, behaviour therapy 
and food provision 
0.00 (-3.05, 3.05)    
No intention to lose weight 
Diet and exercise vs diet 
  -0.74  
(-3.06, 
1.59) 
 
* Significant difference 
 
Head-to-head comparisons 
Direct comparisons of active interventions failed to show significant effect on weight, with 
one exception (Table 8). A Mediterranean diet plus behaviour therapy compared to a 
low-fat diet produced significant improvement in weight at two years (WMD weight 
change -2.8 kg, 95% CI; -3.06,-2.54). 
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Table 8. Table of summary estimates for weight changes from RCTs of weight 
prevention – head-to-head comparisons (WMDs and 95% CI, in kg). 
Comparison 24 months 29/33 months 36 months 
Intention to lose weight 
Diet, exercise (2500kcals/wk), 
behaviour therapy and social 
support vs diet, exercise 
(1000kcals/wk) and behaviour 
therapy 
 -1.96  
(-4.70,0.78) 
 
Behaviour therapy (telephone) vs 
behaviour therapy (mail) 
-0.20 (-0.81,0.41) 
  
Diet, exercise, behaviour therapy 
and meal replacement (group 
dietitian) vs diet, exercise, behaviour 
therapy and meal replacement 
(individual nurse/physician) 
-4.40 (-9.62,0.82)   
No intention to lose weight 
Mediterranean diet and behaviour 
therapy vs low-fat diet 
-2.80*  
(-3.06,-2.54) 
  
Low-fat non-reducing vegan diet vs 
low-fat non-reducing diet 
-2.30 (-6.22,1.62)   
Clinic diet, exercise and behaviour 
therapy vs home diet, exercise and 
behaviour therapy 
-0.90 (-2.43,0.63)  -1.40  
(-3.13,0.33) 
Group higher-intensity exercise vs 
Individual higher-intensity exercise 
0.71 (-1.27, 2.68)   
Lower-intensity home-based 
exercise vs higher-intensity home-
based exercise 
-0.53  
(-2.56, 1.51) 
  
Structured exercise and behaviour 
therapy vs lifestyle exercise and 
behaviour therapy 
-0.74 (-2.0,0.52)   
Diet and exercise (8.4MJ/wk) vs diet 
and exercise (4.2MJ/wk) 
 -3.30  
(-1.04,7.64) 
 
Diet and walking exercise vs diet 
and resistance training exercise 
 1.00  
(-4.04,6.04) 
 
* Significant difference 
 
Clinical outcomes 
Treatment38;42;43 
Orlistat was associated with less weight loss than sibutramine but had a more beneficial 
impact on risk factors. Metformin significantly reduced mortality in 700 obese diabetics at 
ten year follow-up.  A 600 kcal/day deficit/low-fat diet was associated with benefits to 
weight, risk factors, prevention of type 2 diabetes and improvement in hypertension, with 
effects persisting at three years. Diet plus exercise interventions; with and without 
behaviour therapy suggested improvement in type 2 diabetes and control of 
hypertension. 
 
Prevention39 
A 600 kcal/d deficit/low-fat diet can reduce the incidence of type 2 diabetes, improve 
blood pressure control and reduce the need for antihypertensive medication for up to 
three years. Diet plus exercise reduces the risk of type 2 diabetes for up to six years 
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compared to control. Diet combined with exercise and behaviour therapy can reduce the 
risk of type 2 diabetes, hypertension and the metabolic syndrome. The addition of 
exercise to diet can reduce the risk of metabolic syndrome in men. Diet and behaviour 
therapy showed reduced risk of ovarian cancer risk in the final four years of an eight year 
study of 48,000 women; however type 2 diabetes risk was not significantly reduced at 
eight years. 
 
2.1.3 Discussion 
The pattern of results followed expectations; more studies of active versus control 
interventions demonstrated significant weight difference between groups compared to 
studies evaluating additional elements or head-to-head comparisons.   
The aim of individual studies appears to influence results as there are more effective 
studies and a greater amount of weight loss in studies specifically aimed at weight loss 
compared to studies which focus on healthy eating or increased exercise. 
Adults receiving placebo plus diet in the Orlistat and Sibutramine trials, lost less weight 
compared with adults receiving a 600 kcal/day deficit or low-fat diet (in the diet versus 
control trials). This suggests that participants receiving placebo did not adhere to the 
dietary advice and this might have over-estimated the effect of the addition of weight-loss 
drugs to diet compared with diet alone.  
Although few studies followed up participants for longer than three years; the majority of 
studies that produced significant improvement in weight and continued to follow-up 
participants, showed that weight loss was sustained, in some cases for over four years. 
Study interventions were heterogeneous which made the classification of studies difficult. 
The comparisons were underpinned by few studies making it difficult to generalize about 
effective interventions.  There was limited evidence of the effect of weight loss on risk 
factors or clinical outcomes. Approximately 25% of the prevention studies and the 
majority of non-drug treatment studies reported weight outcomes only. Few studies were 
powered to detect differences in morbidity and mortality.   
Risk factor data were limited and inconsistent within and between studies. Risk factors 
and clinical outcomes could improve despite lack of weight loss. For example in one 
study of 700 obese diabetics; Metformin in addition to diet was associated with non-
significant weight change (WMD -0.37 kgs 95% CI; -1.67, 0.93) but significant reduction 
in mortality ((odds ratio (OR) 0.62, 95% CI; 0.42, 0.91)) at 10 years. Risk factors can 
improve independently from weight loss through drug action or improved fitness from 
exercise.  
In some participants some risk factors significantly improved whilst other risk factors did 
not (with or without concomitant weight change). Significant improvements in some risk 
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factors were small changes in absolute values and the clinical value of these 
improvements maybe limited. 
Risk factors often showed no improvement despite significant weight loss.  Possible 
reasons for this include insufficient weight loss to impact on risk factors, insufficient 
power or duration of study to detect significant differences. There did not appear to be 
any pattern between intensity of the intervention and weight change.  
Studies that were sufficiently powered and reported risk factor or clinical outcome data 
were mainly in populations with or at high risk of obesity-related co-morbidities such as 
type 2 diabetes, metabolic syndrome or hypertension. Participants with CVD, 
hypertension or type 2 diabetes appear to lose more or less weight than participants 
without co-morbidities however the pattern is not consistent. More research is required 
into how and why interventions vary in effectiveness in different types of populations. 
There is limited evidence of lifestyle interventions to prevent weight gain in healthy 
normal weight adults within the community.  
 
2.1.4 Conclusion 
In terms of treatment; diets alone and with the addition of exercise or behaviour therapy 
significantly improved weight loss (WMD weight change 4 to 13 kg in first year) 
compared to no-treatment control for up to three years. Adjuncts including drugs, 
exercise or behaviour therapy increased weight loss (WMD weight change 1 to 11 kg in 
first year).  Regarding prevention interventions; diet, alone and with the addition of 
exercise and/or behaviour therapy demonstrated significant weight loss (WMD weight 
change 0.5 to 7 kg) compared to control at a minimum of two years. Exercise and meal 
replacements may be useful tools in the long-term maintenance of weight loss. 
Additional elements (behaviour therapy or exercise) did not always produce better results 
compared with diet alone versus control. Adjuncts to diet were not always more 
beneficial than diet alone. On the whole, direct comparisons of different diets, different 
types and amounts of exercise and varying who and where the intervention was provided 
produced no significant benefit to BMI between groups. 
Diet alone and in combination with exercise and/or behaviour therapy can significantly 
reduce the risk of hypertension, metabolic syndrome and type 2 diabetes compared to no 
treatment control.  
Obesity interventions in adults appear more effective when they are specifically aimed at 
prevention of weight gain compared with interventions which focus more generally on 
healthier eating and increased physical activity. 
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2.2 Systematic reviews of the prevention of obesity in children 
2.2.1 Methodology 
The methods of the Cochrane review40 were based on the methods of the Cochrane 
Collaboration49 and guidelines for systematic reviews in health promotion and public 
health50. Study inclusion criteria were; controlled trials with a minimum duration of 12 
weeks; in children with a mean age of less than 18 years. Types of included interventions 
were diet and nutrition; exercise and physical activity; lifestyle and social support. 
Studies had to report a stated aim to prevent excessive weight gain. The setting could be 
community, school or clinic.  At least one of the following measures had to be reported at 
baseline and follow-up: weight and height; percent fat content; BMI; ponderal index; skin-
fold thickness. 
The search strategy included terms and text words for weight and obesity, intervention 
and setting, combined with a strategy for identifying controlled trials, which was narrowed 
to include only studies that included children. Five electronic databases and various 
websites were searched and experts were contacted. A data extraction form including 
quality assessment was designed, based on the Effective Public Health Practice Project 
Quality Assessment Tool for quantitative studies51. 
The main changes to the methods of the Cochrane review update compared with the 
previous version were to include studies of a shorter duration, widen the search strategy 
and number of databases searched and to include information about context, theory and 
process. 
The methods of the NICE reviews (interventions for pre-school children and school-
based interventions)24;52 included a „best available evidence‟ approach where „best‟ 
refers to evidence from RCTs. If sufficient high quality and up-to-date evidence was 
identified for a specific research question then older studies and/or those using weaker 
study designs were not examined. In the case of limited evidence from high quality 
studies then the „best available‟ evidence was used47.  For evidence of effectiveness; 
both systematic reviews and primary studies of RCTs and controlled clinical trials (CCTs) 
were sought that measured weight (however measured) or dietary intake or physical 
activity levels, at least before and after the intervention, which had to be at least 12 
weeks duration. Included interventions were diet, physical activity, behaviour therapy or 
combinations of such interventions types. Studies were not excluded based on the aim of 
the study. Evidence from qualitative studies based in the UK was also sought for 
corroborative evidence. 
The systematic review of school-based interventions44 which updated the NICE review of 
school-based interventions used identical methodology and inclusion criteria to the NICE 
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methodology with one exception; the updated review only included studies that reported 
a weight outcome. 
Results from the studies of children could not be quantitatively combined, mainly due to 
heterogeneity of outcomes and types of interventions. Each study was summarized and 
described according to the characteristics of participants; interventions; follow up and 
outcomes measured. 
 
2.2.2 Results 
In addition to differences in methodology; the reviews differed by inclusion age and so 
the results are presented by age. 
 
Included studies 
All children under 1840 
Twenty-two studies were included, 19 were school or preschool-based interventions, one 
was a community-based intervention targeting low-income families and two were family-
based interventions targeting non-obese children of overweight parents. Twelve studies 
lasted less than one year and ten studies lasted longer than a year. 
 
Children aged two to five years24;45;52 
Five studies were included, none of which were UK-based. One study was clinic-based 
and the remainder were conducted in a nursery or childcare setting. All interventions 
included family involvement of varying degrees.  
School-children aged four to 16 years24;44;45;52 
Thirty-eight studies were included in the update44; 15 new studies and 23 studies 
included within the NICE obesity reviews24. Seventeen studies were US-based and three 
were UK-based.  Two studies were based in pre-school settings, 23 studies were set in 
primary schools and 13 studies were based in secondary schools. Twenty-two studies 
had follow-up less than one year. Mean baseline BMI ranged from 15.5 kg/m2 to 27.6 
kg/m2 where reported (23 studies). 
 
Weight 
All children under 1840 
Four of 22 (18%) studies were effective in preventing weight gain. 
 
Long-term (12 months or longer) 
Six studies combined dietary education and physical activity interventions; five resulted 
in no difference in overweight status between groups and one (Planet Health) resulted in 
improvements for girls receiving the intervention, but not boys.  Planet Health aimed to 
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improve diet and increase physical activity and reduce television viewing. The adjusted 
OR showed significant improvement in percentage obesity in girls but not boys at 18 
months (girls; OR 0.47; 95% CI 0.24 to 0.93, p = 0.03). Two studies focused on physical 
activity alone of which one appeared to be effective in preventing obesity. Two studies 
focused on nutrition education alone, but neither was effective in preventing obesity. 
 
Short-term (less than one year) 
Two of four physical activity interventions produced minor reductions in overweight status 
in favour of the intervention. An aerobic dance intervention demonstrated significant 
improvement in mean BMI at 12 weeks in intervention girls compared with control girls (-
0.8 kg/m2 vs 0.3 kg/m2, respectively). An intervention to reduce television and video use 
showed significant difference in mean BMI between groups at 6 months (-0.45 kg/m2, 
95% CI -0.73 to -0.17, p = 0.002). The other eight studies were combined diet and 
physical activity interventions and none had a significant impact on weight.  
 
Children aged two to five years24;45;52 
Three of the five studies (two diet and exercise interventions and one diet intervention) 
found some evidence that the intervention prevented unhealthy weight gain leading to 
obesity, compared with controls.  
 
School-children aged four to 16 years24;44;45;52 
Fifteen of 38 studies (39%) were effective. One of three diet studies, five of 15 physical 
activity studies and nine of 20 combined diet and physical activity studies demonstrated 
significant and positive differences between intervention and control for BMI.  
 
2.2.3 Discussion 
The studies were heterogeneous in terms of design, participants, intervention and 
outcome measures; making it impossible to combine study findings using statistical 
methods. It is difficult to generalize about which interventions are effective and how the 
range and extent of intervention components influence effectiveness.  
The Cochrane review40 included only studies specifically aimed at preventing weight gain 
and demonstrated lack of significant benefit to weight (particularly from combined diet 
and activity interventions) from the limited available evidence. The NICE review24 and its 
update44 (which included studies not specifically aimed at preventing weight gain) 
demonstrated optimistic but inconsistent results. These differences in review conclusions 
demonstrate the importance of what evidence is considered when assessing the 
effectiveness of interventions. 
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Limited evidence from the Cochrane review40 suggests that many diet and exercise 
interventions to prevent obesity in children are not effective in preventing weight gain, but 
can be effective in promoting a healthy diet and increased physical activity levels. Half 
(3/6) of the physical activity interventions showed a small but positive impact on BMI 
status.  
Limited evidence from the NICE review24 of pre-school children indicates that 
interventions which focus on the prevention of obesity through improvements to diet and 
activity appear to have a small but important impact on body weight that may aid weight 
maintenance.  
Findings from the most recent review of school-children44 are inconsistent and mainly 
short-term, but overall suggest that combined diet and physical activity school-based 
interventions may help prevent children becoming overweight in the long-term. Physical 
activity interventions, particularly in girls in primary schools, may help to prevent these 
children from becoming overweight in the short term. However the same interventions 
were not tested across a range of ages and effectiveness could be due to the type of 
interventions used in this age group rather than the age per se. 
Despite lack of conclusive results in terms of weight, the majority of studies 
demonstrated significant improvement in diet and activity behaviours such as increasing 
fruit and vegetable intake, promoting water consumption, increasing active play and 
physical education in schools. Possible reasons why studies could show significant 
benefit in terms of behaviour change but not BMI is uncertain. Some studies were not 
adequately powered to detect differences between groups and some of the interventions 
were not of sufficient length or intensity to produce a change in BMI. Assessment of 
effectiveness can also be exacerbated by weaknesses in assessment measures. 
 
2.2.4 Conclusion 
The findings are inconsistent and mainly short-term, but overall suggest that combined 
diet and physical activity school-based interventions may help prevent children becoming 
overweight in the long-term. It is unclear what elements of interventions are consistently 
effective. 
The aim of individual studies within reviews appears to impact on reported outcomes and 
therefore overall review conclusions. Results for BMI appear less effective if confined to 
studies specifically aimed at weight gain prevention in children rather than improving 
healthy eating and physical activity.  
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2.3 Systematic reviews of obesity interventions targeted at 
black, minority ethnic groups, vulnerable groups and 
individuals at vulnerable life stages 
 
2.3.1 Methodology 
The methods of the NICE reviews of interventions aimed at black, minority ethnic groups, 
vulnerable groups and vulnerable life stages24;46 adopted a „best available evidence‟ 
approach in line with NICE methodology (discussed in 2.2.1). For evidence of 
effectiveness; both systematic reviews and primary studies of RCTs and CCTs were 
sought that measured weight (however measured) or dietary intake or physical activity 
levels, at least before and after the intervention which had to be at least 12 weeks 
duration. Studies were not excluded based on the aim of the study. Evidence from 
qualitative studies based in the UK was also sought for corroborative evidence.  
Black and minority ethnic groups included minority population groups with relatively high 
rates of obesity within the UK53.  Vulnerable groups included populations with relatively 
high risk of obesity based on inequality (for example inequality of income or education) 
along with children in care and in special schools and adults in institutions. Other 
vulnerable groups included individuals with learning difficulties, special needs and 
developmental disorders53. Vulnerable life-stages included smoking cessation, 
pregnancy and menopause25;53.  
The review of postmenopausal women41  included both systematic reviews and primary 
studies of RCTs and CCTs with a minimum duration of 24 weeks (because the focus was 
on long-term health outcomes). All women were required to be postmenopausal and 
have a BMI of at least 25 kg/m2 at baseline. The search strategy used the keywords 
„weight loss‟ and „weight reduction‟ combined with „postmenopaus$‟ and phase I of the 
Cochrane search terms for identifying RCTs54. The search was run in MEDLINE, 
EMBASE, PsychINFO and CINAHL from database conception to May 2006. 
Both reviews included interventions of diet, physical activity, behaviour therapy or 
combinations of such interventions types. Each study was summarized and described 
according to the characteristics of participants; interventions; follow up and outcomes 
measured. 
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2.3.2 Results 
Included studies 24;46 
Black and minority ethnic groups 
No studies were identified that assessed lifestyle interventions in BMEGs or low-income 
groups in the UK.  
Vulnerable groups 
Two studies in adults with disabilities and one study in children with disability were 
identified. 
Vulnerable life stages 
Three ante-natal interventions and seven smoking cessation studies were identified. Two 
systematic reviews and one long-term RCT in peri-menopausal women were included. 
 
Weight 
Vulnerable groups 
Disability24;46 
A 12-month intervention to reduce obesity using health practitioner input with adults with 
learning difficulties in Manchester, UK, showed that in the control group obesity levels 
deteriorated in 10.2%, remained the same in 81.6% and improved in 8.2%. In the 
intervention group 10.5% deteriorated, 63.2% remained the same and 26.3% improved. 
Mean BMI did not appear to significantly differ from baseline or between groups at one 
year.  
A 12-week cardiovascular and strength exercise programme in obese adults with Down‟s 
syndrome based in the USA showed a significant difference in weight but not BMI 
between groups at 12 weeks. There was a slight reduction in weight at 12 weeks in the 
intervention group whereas weight increased in the control group. 
A 9-month aerobic exercise programme (45 minutes, four times per week) in 20 nine 
year old children with spastic cerebral palsy, based in Germany, reported „no changes‟ in 
fat mass compared with an average 1.1 kg increase in the control group. This small 
study was not powered to detect significant changes in weight.  
 
Vulnerable life stages 
Pregnancy24;46 
Three studies (all based in the USA) assessed antenatal interventions, two in low-income 
women. Two studies were specifically aimed at preventing excessive weight gain during 
pregnancy, one study was an RCT, one was a CCT and one study used historical 
controls for the comparison group.  
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The RCT significantly reduced the percentage of normal-weight women (but not 
overweight women) that exceeded the weight gain goal, however the intervention had no 
significant effects on average weight gain from pre-pregnancy to delivery and weight 
gains were comparable between black and white women. 
The CCT showed that women in the exercise intervention group gained less weight in 
the latter stages of pregnancy (although still within normal range). The women in this 
study were physically active at baseline and were self-selecting in choosing whether to 
continue exercising (intervention group) or to reduce exercise during pregnancy (control). 
In the study using historical controls, there was significant reduction in excessive weight 
gain in the low-income women and significant reduction in the risk of weight retention 
women who were overweight.  
 
Smoking24;46 
Seven studies assessed interventions to prevent excessive weight gain during and after 
smoking cessation programmes. Three studies were diet plus exercise interventions, two 
were exercise interventions; one was a food replacement intervention and one a 
cognitive-behavioural therapy intervention for women with „weight concerns‟. The 
majority of the studies were small, based in the USA; included women aged 30 to 40 
years who smoked 19 to 32 cigarettes a day.  
Three of the seven interventions significantly improved abstinence rates, three showed 
no significant difference in abstinence rates and in one study both an individualised and 
non-individualised diet plus aerobic exercise intervention increased the risk of smoking 
compared to control at 12 months.  
In six studies the diet and/or exercise intervention did not significantly reduce weight gain 
compared to control. Weight gain ranged from 1 to 9kg across all the groups in the seven 
studies. Cognitive-behavioural therapy for weight concerns significantly attenuated 
weight gain (and improved smoking abstinence) compared with standard smoking 
cessation in women concerned about their weight (2.5 kg vs 7.7 kg respectively).  A third 
comparison group which included a 500 kcal/day deficit diet did not show significant 
difference in weight compared to control (5.4 kg vs 7.7 kg respectively).  
 
Menopause24;41;46 
A systematic review of 18 good quality RCTs of at least eight weeks duration, assessed 
the effect of exercise in over 1800 healthy postmenopausal women (aged 50–65 years). 
Body composition showed improvement in nine studies and most studies showed a small 
loss of weight and body-fat. The most effective results were accomplished in three 
studies with overweight participants who used weight-reducing diets in combination with 
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exercise training. The mean weight loss ranged from 2 to 10 kg between 12 weeks to 
one year. 
Evidence from one high quality RCT suggests that a tailored programme with a 
behavioural element addressing both dietary intake and physical activity can prevent 
excess weight gain in perimenopausal women. At 54 months, 55% of the intervention 
women were at or below their baseline weight compared with 26% in the control.  The 
intervention demonstrated significant improvement in weight, waist circumference, BMI, 
percent body-fat and fat-free mass compared with control at 54 months. 
The systematic review of postmenopausal women41 included four RCTs, one CCT and 
one systematic review. All active-treatment arms demonstrated significant improvements 
in weight and body composition from baseline. Weight loss in active-treatment arms 
varied from 1.5 kg to 9 kg over 6 to 12 months.  Significant effects between treatment 
groups were shown only in intervention versus control studies. Significant weight loss 
was not accompanied by beneficial changes in cardiovascular risk factors in the majority 
of studies. None of the studies reported disease outcomes.  
 
Summary24;41;46 
The effectiveness of interventions among BMEGs, lower-income groups and other 
vulnerable groups in the UK is unknown. There is a dearth of evidence on the 
effectiveness of interventions among individuals with a disability. Limited short-term 
evidence suggests that a cardiovascular and strength exercise intervention may prevent 
excessive weight gain in overweight adults with Down‟s syndrome.  
The antenatal studies varied in terms of aim, quality and population. The evidence is 
limited but suggests that antenatal interventions aimed at reducing excessive weight gain 
can be effective in low-income pregnant women but the impact of baseline weight 
remains unclear. Antenatal interventions including exercise, diet alone and in 
combination, can reduce excessive weight gain in pregnant women. Excessive weight 
gain during pregnancy is correlated with postpartum weight retention and so antenatal 
interventions may help to curb the increasing level of obesity amongst women.  Since the 
NICE review24 was produced, an RCT of a dietary intervention has been published which 
showed a significant reduction in excessive weight gain in obese pregnant white women 
between 15 and 36 weeks gestation compared with control55. This evidence strengthens 
the above conclusions. 
Smoking cessation interventions incorporating weight management interventions may 
increase continuous abstinence rates but the long-term impact on weight remains 
unclear.  
 42  
Weight-reducing diets in combination with exercise training can significantly improve 
body composition in overweight postmenopausal women. A diet, exercise and behavioral 
therapy intervention significantly improved BMI and other anthropometric measures in 
women experiencing the menopause, with effects sustained at 54 months.  
Lifestyle interventions can produce significant weight loss compared to no-treatment 
control in overweight postmenopausal women and have the potential to improve disease 
outcomes associated with overweight. Significant weight loss was not accompanied by 
beneficial changes in cardiovascular risk factors in the majority of studies. Many of the 
studies were probably underpowered and too short in duration to detect change in risk 
factors. The study that produced the greatest weight loss demonstrated improvements in 
risk factors and it may be that only this one study produced sufficient weight loss to 
significantly improve risk factors.  
 
2.3.3 Discussion 
There is a severe lack of evidence from lifestyle interventions to prevent excessive 
weight gain that are targeted and tailored to ethnic minority groups and other vulnerable 
groups at increased risk of obesity who are living within the UK. The need for intervention 
is greatest amongst these groups who are at increased risk of obesity.  
In this case, results of studies based outside the UK are not generalizable to minority 
ethnic groups in the UK. The link between socioeconomic status and obesity in the UK is 
complex and maybe associated with the degree of relative social inequality rather than 
absolute levels of income18. The socio-political context of low-income populations within 
the UK (which often includes ethnic minority groups with higher risk of obesity) is 
different from low-income and ethnic minority populations in other countries. 
Pregnant women are at increased risk of obesity and obesity impacts on reproductive 
health and increased risk to health during pregnancy (caesarian, haemorrhage, 
infection)14. Preventing excessive weight gain during pregnancy and reducing overweight 
prior to conception will improve the health of these women and the health of their 
children. Obese pregnant women are less likely to breastfeed and to breastfeed for a 
shorter duration compared with normal weight women56. Breastfeeding exclusively for six 
months is associated with reduced obesity in children however this evidence is mainly 
derived from observational studies. The largest (17 000 infants) and longest (6.5 years) 
breastfeeding intervention to date, did not reduce obesity and CVD risk factors at six 
years despite significantly increasing breastfeeding57. The Promotion of Breastfeeding 
Intervention Trial (PROBIT) was a cluster-randomised trial of a breastfeeding promotion 
intervention based on the World Health Organisation (WHO)/United Nations International 
Children‟s Emergency Fund (UNICEF) Baby-Friendly Hospital Initiative.  
 43  
Exclusive breastfeeding for six months may not constitute an effective public health 
strategy for reducing obesity but may contribute to an obesity prevention strategy by 
helping new mothers to reduce weight retention and establishing good weaning 
practices.  
Weight gain prevention interventions incorporated into smoking cessation programmes 
may help women who are concerned about their weight to give up smoking.  
More research is needed into the timing and intensity of diet and exercise interventions 
to prevent excessive weight gain during and post-menopause. Post-menopausal women 
are at increased risk of CVD and require long-term follow-up to assess the effects of 
weight gain prevention on clinical outcomes. 
 
2.3.4 Conclusion 
There is no evidence regarding whether or how obesity interventions need to be modified 
for ethnic minority groups and other vulnerable groups living in the UK. There are social 
inequalities in the prevalence of obesity. Interventions addressing obesity on a 
population-wide scale may appear beneficial but may in fact be widening health 
inequalities between groups that vary in risk for obesity. 
Future interventions need to be targeted and tailored to high-risk groups such as minority 
ethnic groups and those with low-income and limiting disabilities. 
Interventions to prevent excessive weight gain during pregnancy, menopause and 
smoking cessation all have the potential for significant health benefits. 
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Chapter 3 
3 Methods of evaluating effectiveness 
3.1 Why results from similar systematic reviews may differ 
What evidence is included and how the evidence is assessed has important implications 
for the evaluation of the effectiveness of obesity interventions. 
 
Differences in review protocols  
Studies specifically aimed at preventing weight gain might be expected to have a greater 
likelihood of demonstrating effectiveness in terms of benefit to weight than studies not 
specifically targeting obesity prevention. Evidence from studies in adults in the NPRI 
review39 showed that the effective interventions included a greater proportion of studies 
that intended adults to lose weight compared with studies not aimed at weight loss.  
These studies that intended to produce weight loss also produced a greater amount of 
weight loss.   
This does not appear to be the case in the reviews of children. There were a smaller 
percentage of effective studies that aimed to prevent weight gain compared with studies 
not specifically targeting weight (18% effective studies in Cochrane review40, 39% 
effective studies in updated review of school-based interventions44). 
A similar review of obesity prevention in children58 included studies not specifically aimed 
at preventing weight gain and this contributed to a greater percentage of studies which 
showed effectiveness compared to the Cochrane review40.  The review by Doak et al.58 
included 24 studies with 17 categorised as effective (71%) whereas in the Cochrane 
review40 only four of the 22 studies were categorised as effective (18%). Both reviews40;58 
share similar aims; however only ten studies appeared in both reviews due to differences 
in inclusion criteria and assessment of outcome59.   
Whether to include studies with aims not specific to preventing weight gain is a 
contentious issue and partially explains the discrepancy between the results of the two 
reviews59. Applying identical inclusion criteria to both reviews showed that 50% of 30 
included interventions were effective and excluding studies not aimed at preventing 
weight gain showed that 42% (10/24) of interventions were effective59.  
 
Differences in outcome measures 
Triallists report various anthropometric measures including percentage body-fat, 
percentage overweight, percentage obese, BMI, BMI z-score, BMI percentile, waist 
circumference, waist-hip-ratio, skinfold thicknesses and weight. The use of such assorted 
outcome measures makes comparisons between studies difficult. As discussed in 
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Chapter 1; from a public health perspective, BMI is a good measure of prevalence 
however other measures of excess fat maybe important when assessing an individual, 
particularly a child or a person of ethnic minority status.   
Even if one measure of excess fat is used in studies, differences in results also relate to 
the methods used within studies to classify weight status of children. The most 
commonly applied thresholds for overweight and obesity are derived from the IOTF5 and 
the 1990 British centile charts60. The IOTF reference population is much larger and more 
representative of different ethnic groups however it is more stringent and usually 
produces a lower percentage of obesity (even when the UK population is used) 
compared to the 1990 British centile charts. One methodology applied universally would 
eliminate discrepancy in prevalence due to the use of different classifications and enable 
more reliable comparisons of data between studies. 
Obesity prevention interventions aim to reduce the number of people becoming 
overweight and prevent the amount of overweight from increasing within those already 
overweight (i.e. mean BMI and prevalence of overweight). In order to evaluate the 
effectiveness of an obesity prevention strategy it is crucial to assess how change in 
prevalence and change in mean BMI has occurred. For example if prevalence change is 
due to weight loss in the overweight or reduction in mean BMI is due to reduced 
incidence in normal weight.  
Prevalence of obesity can change significantly without affecting the mean BMI because 
prevalence involves a minority of the sample being above the specified cut-off point, 
whereas the mean BMI includes every participant in the sample. For example, over time 
a few participants could increase their BMI enough to cross the cut-off point and become 
overweight. There will be a smaller number of participants who lose BMI and cross the 
cut-off threshold in the opposite direction, but the change in prevalence is the balance of 
these two shifts. Relative few participants would need to reduce their BMI to compensate 
for the rising BMI of participants who have crossed the cut-off threshold, so mean BMI 
would stay the same but prevalence would increase. 
Discrepancy between results of reviews can arise from differences in assessment of 
outcome measures. The Cochrane review40 classified an intervention as effective if mean 
change in BMI was statistically significant and in favour of the intervention. A study was 
classified as not effective if, for example, prevalence was significantly reduced but mean 
BMI was not. The review by Doak et al.58 classified an intervention as effective if any 
outcome measure (of weight) showed significant benefit in favour of the intervention. 
When comparing the ten studies included in both reviews this discrepancy in assessment 
becomes clear: the Cochrane review40 assessed three out of the 10 (30%) studies as 
effective whereas the review by Doak et al.58 assessed six out of the same 10 (60%) 
interventions as effective59.  
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In determining the effectiveness of an obesity intervention it is difficult to decide which 
outcome measures to focus on. One method is to assess the effectiveness of the 
outcome measure which best matches the individual study aim. Another method involves 
grading the outcomes by using a hierarchy so that clinical outcomes take precedence 
over behaviour change outcomes which in turn take precedence over change in 
knowledge or attitudes.  Another method is to choose an outcome measure which is 
considered most relevant to obesity prevention (usually a measure of weight). If there is 
inconsistency between the effects of multiple outcome measures within a study, then 
overall effectiveness can be based on the balance and grade of the individual outcomes.  
 
Differences in assessment of participants 
Differences in results can arise depending on whether all participants are assessed 
according to the groups they were randomised into (known as „intention to treat‟) or 
whether only participants who completed the study were assessed. Some studies only 
assess participants who adhered to the treatment protocol and so groups become almost 
self-selected.  
„Intention to treat‟ studies do not exclude any participant; participants who are lost to 
follow-up (drop-outs) can have their last observed outcome measurements carried 
forward to the end of the assessment period. If there are significant differences between 
participants who have dropped-out and those that have completed the trial this can bias 
the results. For example if the majority of drop-outs do so because they have reached a 
plateau and are failing to lose any more weight, their last measurements could be when 
weight loss was greatest. Failure to maintain weight loss and weight regain is common 
(usually seen after six months in weight loss trials in adults) and so including these 
participants in final assessment - by carrying the last observation forward – will tend to 
produce a more favourable result for the intervention. 
In reality some participants will drop-out or not adhere to an intervention and a major 
focus of public health interventions is how they perform in real life across the whole 
population. By studying the characteristics of participants who do not adhere to an 
intervention, future interventions can be targeted and tailored more appropriately.  
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3.2 Synthesizing different types of data 
‘Best available evidence’ approach 
For the HTA review, conducted in 2001, it was relevant to employ the methods of the 
Cochrane Collaboration49 because the review was a first attempt at synthesizing a 
relatively large amount of evidence from RCTs of effectiveness of obesity treatments in 
adults. As a research assistant I was involved in every process of the HTA review38 post 
protocol. 
Since the HTA review38 there has been increasing awareness that end-users require a 
variety of evidence. The systematic reviews commissioned by NICE24;47;53 aimed to 
provide an evidence base for the development of guidance to enable decision makers 
and practitioners to implement effective public health obesity interventions and so a „best 
available evidence‟ approach was adopted which involved synthesizing different types of 
data. If sufficient high quality and up-to-date evidence was identified for a specific 
research question then older studies and/or those using weaker study designs were not 
examined. In the case of limited evidence from high quality studies then the „best 
available‟ evidence was used47.   
I adopted a „best available evidence‟ approach partly because of my experience of 
limited evidence from obesity interventions in children, also to include information on 
process outcomes and context, and in order to enable the GDG to develop guidance. I 
believe the end-users of systematic reviews are of paramount importance because they 
help to define the purpose of a review and reviewers should consider the needs of the 
end-user throughout the review process. This belief was reinforced during the production 
of the NICE reviews24 when I presented evidence in person to the GDG. The GDG 
required minute detail about individual interventions and this emphasized the importance 
of the need to question the relevance of evidence to practice, in order to translate it into 
practice. 
The NICE reviews24 had additional research questions (as well as effectiveness) which 
were crucial in order to develop guidelines for practice. As lead reviewer for the Obesity 
Collaboration Centre at Teesside University I understood that it would be unhelpful to the 
GDG to conclude in areas of limited evidence that „there was a lack of high-quality 
evidence‟ and more constructive to appraise what evidence existed and additionally, to 
gain insight into what types of interventions have the potential to be effective. 
Evidence from the HTA review38 and the Cochrane review40 highlighted the discrepancy 
and lack of long-term data for children compared to adults. A „best available evidence‟ 
approach meant that the NICE protocol for the obesity reviews could reflect this; RCTs of 
at least one year were included in the NICE review of treatments for adults and lesser 
quality studies of shorter duration and not specifically aimed at obesity prevention, were 
included in the NICE reviews of prevention interventions for children.  
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My experience of using a „best available evidence‟ approach for the NICE reviews24 
enabled me to appreciate the value to the end-user of incorporating process outcomes 
and widening the inclusion criteria for evidence. In response I made changes to the 
protocol of the Cochrane update of obesity prevention interventions in children40 to reflect 
the broader approach of public health reviews in terms of the information it provides for 
public health decision makers. The search strategy was widened and the number of 
databases searched was increased, studies of shorter duration were included and details 
regarding theory, process and context were extracted.  
Following the update of the Cochrane review40 I undertook an update of the schools 
review44 and a review of weight reduction in postmenopausal women41, in which I was 
responsible for each stage of the reviews, from conception to publication. Both reviews 
are useful to the end-user for different reasons. The update of the schools review44 builds 
on the evidence base by capturing a relatively large number of studies published since 
the NICE review24. The update strengthens the evidence that school-based interventions 
combining diet and exercise can significantly prevent excessive weight gain in school 
children. In contrast, the review of weight reduction in postmenopausal women41 
highlights that there is still a dearth of evidence of interventions amongst vulnerable 
groups which may have the greatest need for intervention. 
In the area of obesity research there is an ever increasing plethora of reviews and to 
avoid duplication of effort it may be more sensible to build on the evidence contained 
within these reviews rather than search databases and journals for primary studies. One 
potential weakness in using existing reviews for identifying relevant studies is reliance 
that these reviews were produced in a systematic and robust manner and captured all 
relevant evidence. A systematic review of systematic reviews can make this method 
more robust however to have confidence that all relevant studies have been captured it 
is often necessary to systematically search for both reviews and primary studies.  
The „best available evidence‟ approach47 used in the NICE obesity reviews24 enabled the 
inclusion of both systematic reviews and individual studies from one systematic search 
for both types of evidence.  I have since modified this approach for the NPRI review39 by 
first searching for reviews then searching for individual studies published after the NICE 
guidance; which were used to „top up‟ the evidence found within the systematic reviews.  
 
Combining evidence 
Quantitatively combining results from RCTs by statistical meta-analysis of the data 
provides a „gold standard‟ for quantitative synthesis. However public health interventions 
are often complex and not amenable to meta-analysis; individual behaviour change 
outcomes are insufficient to assess such interventions. If there is limited evidence from 
good quality studies then there is a case for considering evidence from other study 
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designs. In addition there is an inherent danger of separating the effectiveness of an 
intervention from its context.  
Systematic reviews need to address additional research questions to those regarding 
effectiveness such as information on process (including appropriateness, 
implementation, feasibility, acceptability and sustainability) and the context of individual 
behaviour change in relation to the community and wider socio-political environment61. 
Effectiveness can be influenced by how the intervention is provided, who provides it and 
where it is provided. End-users require both outcome and process data and I believe that 
methods of combining these two types of data can enhance understanding of why and 
how interventions can work. 
There are two main ways of synthesizing qualitative and quantitative data either in 
addition or instead of meta-analysis. Textual narrative describes the study findings by 
grouping similar studies together whereas thematic synthesis attempts to find common 
elements across the different study designs. Both methods have strengths and 
weakness, textual narrative is better at describing the scope and strength of the evidence 
but can read rather like „telling a story‟ and be rather cumbersome when dealing with a 
large number of studies. A thematic approach may be more interesting for the reader and 
more appropriate for hypothesis testing but may obscure heterogeneity and study 
quality62.  
My initial approach to combining data was a combination of textual narrative and 
thematic synthesis which involved describing the interventions and comparing similarities 
and differences to assess any emerging patterns. However the end-user requires an 
appraisal of the strength of the evidence and this spurred further methodological 
development. 
When using a „best available evidence‟ approach, evidence can be graded by levels in 
terms of its applicability to the research question. For example when evaluating studies 
modified for BMEGs in the UK, „level one‟ evidence could be studies directly related to 
this population, „level two‟ evidence could be other vulnerable groups such as low-
income families in the UK and „level three‟ evidence could be from other BMEGs and 
low-income populations outside the UK. Effectiveness could be assessed and stratified 
by the level of evidence within which the individual studies could be graded by quality 
and type of outcome (clinical, behavioural, knowledge). In addition to using all the 
available evidence and identifying any gaps; this approach helps to compare 
interventions modified for BMEGs with interventions in majority populations.  
The „best available evidence‟ approach47 used within the NICE obesity reviews24 enabled 
qualitative and quantitative evidence to be combined. Where there was limited evidence 
from high quality studies, lower quality evidence was used for corroboration and to 
provide information on process indicators which added context and improved 
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understanding relating to the effectiveness of interventions. Specifically with regard to the 
NICE review of black, minority ethnic groups; evidence from ethnic minorities in the USA 
was used in the absence of UK-based evidence. As evidence from outside the UK is not 
directly relevant in this case, the evidence was „downgraded‟ in that caution was applied 
in making any generalizations about the results of these interventions. Thus the strength 
of the evidence helps in terms of assessing the level of confidence in the effectiveness of 
an intervention. 
‘Mapping’ the evidence.  
It is often useful in reviews of complex public health interventions to map the included 
studies according to the spheres of influence that the intervention aims to impact upon. 
For example an intervention could focus on individual behaviour change, change within 
the family, changes to the immediate environment such as healthier food in school 
canteens or changes to the wider environment such as improved food labeling in 
supermarkets and free access to leisure facilities or an intervention could focus on all or 
some of these spheres. By mapping the studies in this way we can see where there is 
the most evidence and where there is limited evidence and whether effectiveness varies 
according to the spheres of influence of an intervention.  
In practical terms, mapping the evidence helps to organize the data so that similarities 
between effective interventions can be highlighted and differences between effective and 
non-effective interventions can be compared and any emerging themes can be 
described. Where lack of data are highlighted this can lead to further searching for 
evidence further down the quality hierarchy.  Non-intervention evidence from cohort, 
survey or other qualitative studies can be used to corroborate effectiveness data63. It can 
add context and improve understanding about why an intervention is effective or not. 
My current method of combining evidence in includes a „stepped approach‟ which is a 
flexible approach whereby evidence from various study types is initially identified and 
then I grade the evidence by quality and relevance to the research question and „map‟ 
the evidence by spheres of influence. I compose a hierarchy of theoretical evidence 
(which prioritizes evidence at the top) and then match the identified evidence within the 
hierarchy. This enables the best available evidence to be combined, provides 
corroborative evidence to aid understanding, highlights gaps in the research and enables 
the reviewer to appraise the strength of all available evidence.  
 
Summary 
Without these developments in methodology I would have reported and concluded on a 
lack of available evidence to answer many of the research questions and the evidence-
base would have remained limited. These developments in methodology have enabled 
more constructive work because in areas where there is severely limited evidence I have 
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been able to suggest potential beneficial elements of interventions which require further 
investigation. Combining corroborative evidence with effectiveness evidence and 
information on process and context has provided insight into how and why interventions 
have the potential to produce beneficial behaviour change.  
By grading the evidence by relevance to the research questions I have been able to 
ensure reviews remain focused on the original research questions and avoided the 
inherent danger of focusing on areas which are less relevant because stronger evidence 
exists. Combining and appraising the best available evidence has enabled decision-
makers to produce policy and practice guidance which is graded by the strength of the 
evidence. Without mapping the spheres of influence of interventions, the reviews would 
have failed to capture the importance of the obesogenic environment and the context 
within which individual behaviour change is constrained. 
 
3.3 Modeling of potential interventions 
Significant change in behaviour in terms of improvement in healthy eating or increase in 
physical activity, does not necessarily demonstrate improvement in weight in children. 
Significant improvement in weight is not always accompanied by beneficial changes in 
risk factors or clinical outcomes in adults. Lack of effectiveness can be due to inadequate 
sample size, duration or intensity of an intervention. A study might not have been 
sufficiently powered to detect differences in clinical outcomes, or the intervention could 
have been too short, or the amount of behaviour change insufficient to impact on weight.   
When we don‟t know what type of intervention will be effective (and this is currently the 
situation with regard to children) we can look at the evidence from a different angle; how 
effective would an intervention need to be in order to have a beneficial impact on 
population weight and health? Also what amount of behaviour change is required in 
order to produce this benefit to weight and health?  
In the absence of longer-term data from interventions and the use of intermediary 
measures such as dietary intake and activity levels, modeling becomes a useful tool. 
Modeling of weight change in relation to energy intake and output can be used to predict 
the effect of an obesity intervention on population weight. Modeling enables targets to be 
established within public health interventions that will help to prevent excessive weight 
gain at population level.   
Modeling techniques vary and produce different estimates of the energy gap required (in 
terms of kcals/day) to prevent excessive weight gain64;65. Hill et al.64 estimate that an 
energy deficit of 100 kcals/day is required to prevent excessive weight gain in adults and 
Butte et al.65 estimate the energy gap may need to be around 260 kcals/day in children. 
More detailed evaluation of the behaviour change achieved within interventions and 
comparison with the estimates used within these modeling techniques would enable 
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assessment of whether the behaviour change was enough to impact on weight and the 
amount of weight change that could be expected over a certain period of time.  
A minority of obesity intervention trials in adults (and even less in children) report risk 
factor outcomes. The HTA review38 of obesity treatment in adults modeled the impact of 
weight reduction on change in risk factors. Regression analysis demonstrated that a 
weight loss of 10 kg was associated with a fall in total cholesterol of 0.25 mmol/L (about 
5%) and a weight loss of 10% was associated with a reduction in systolic blood pressure 
of 6.1 mmHg. More weight loss was associated with greater improvement in lipids.  
Modeling the impact of change in behaviour on weight and the effect of weight change 
on risk factors are crucial in order to assess the cost-effectiveness of an intervention and 
enable decision makers to implement effective public health interventions. It is 
sometimes necessary to take a „leap of faith‟ that interventions which show a significant 
improvement in healthy eating and/or physical activity and thus significant improvement 
in the right direction, will prevent obesity and obesity-related diseases in the long-term. 
Modeling allows practitioners to appreciate the clinical significance of statistically 
significant changes in weight, or indeed behaviour, which are reported in systematic 
reviews of obesity interventions.  
 
3.4 Conclusions 
Systematic reviews need to be user-friendly and flexible to the demands of the research 
question. Preliminary mapping of all available evidence should be an explicit part of the 
review process. Both outcome and process evaluations are crucial elements which need 
reporting in studies and in systematic reviews. Continuing development of methodology 
is required with regards to combining evidence from different types of study design. 
Future methodological development is needed to evaluate environmental change and 
policy driven interventions.  
My reviews have focused on the end-user, mainly decision-makers for policy and 
practice and in doing so they have become more relevant to practice. There is an 
increased awareness of the needs of public health decision-makers and this is reflected 
in a broader approach now taken to producing systematic reviews of public health 
interventions. Using the „best available evidence‟ enables the sharing of appraised 
evidence rather than censoring of evidence which is not of the highest quality and this is 
a constructive approach to public health research. 
My reviews have encouraged better reporting of process evaluations, context and the 
impact of the environment, which is demonstrated in recent publications of obesity 
interventions. My reviews have highlighted a lack of evidence of interventions in 
vulnerable groups and studies are now being conducted in pre-school and other 
vulnerable groups within the UK which  hold promise for the future of obesity research.  
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The methodology which I have developed which reflects the importance of using best 
available evidence, corroborative evidence and evidence about process and context, 
together with methods of combining such evidence, is recognised within the wider 
research community. The Cochrane Collaboration has developed guidelines specifically 
for conducting systematic reviews within public health50.  
In addition the „Preferred Reporting Items for Systematic reviews and Meta-Analyses‟ 
(PRISMA) published in July 200966 reflect the recognition that systematic reviewing is an 
iterative process which requires a flexible protocol that can be modified if necessary in 
response to the nature of the identified evidence. It is important to point out that this is 
opposite to developing a protocol to identify only a selection of evidence. PRISMA 
includes a flow diagram which details the number of studies included in both quantitative 
and qualitative analysis and reflects the importance of doing both. 
The Foresight report18 concluded that the length of time needed to fill the evidence gaps 
was at odds with the need for urgent action and I would argue that any action needs to 
be properly evaluated especially if there is a move away from evidence-based practice 
towards practice-based evidence. Developments are needed in methods to evaluate the 
effect of new policy interventions such as the population-wide social marketing campaign 
„Change4Life‟67 which promotes lifestyle change to prevent obesity. This provides an 
opportunity to develop methods to evaluate the impact of population-wide interventions 
on the complex interaction between social inequality and obesity over the life-course. 
 
3.5 Professional development - reflections 
Between 2001 and 2005 I progressed in my career from research assistant on the HTA 
review38 to lead reviewer at the Obesity Collaborating Centre at the University of 
Teesside.  
My professional development has been underpinned by an evolving awareness and 
understanding of the complexity of producing high quality user-friendly systematic 
reviews within obesity research. As this awareness has occurred I have moved away 
from a medical model of health (which does not account for the role of social factors in 
health) and adopted a public health perspective. This perspective has helped me to view 
the individual and their behaviour within the context of an obesogenic environment and to 
„make sense‟ of the evidence derived from interventions. My developments in 
methodology are underpinned by this perspective. 
I find myself in a distinctive position of having acquired a comprehensive knowledge of 
the current state of obesity intervention research. I feel privileged to have had the 
opportunity to use my skills as a systematic reviewer to enable the GDG to develop 
guidance to combat obesity24 and experience first-hand the impact that my work has had 
in influencing this process and thereby influencing practice.  
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During this time I came to realise that the production of a systematic review is never a 
stand-alone activity but rather it is one element in the process of translating evidence into 
practice and it is therefore vital that each review is user-friendly and fit for purpose. 
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Chapter 4 
4 Conclusions 
4.1 Review of aims and objectives 
This chapter summarizes the main findings according to the objectives defined in the 
introduction (page 1) and highlights the contribution of the submitted body of work to the 
overall body of knowledge. 
 
O1 to evaluate the effectiveness of interventions in terms of improving weight 
status, risk factors for disease and disease 
Diets alone and with the addition of exercise and/or behaviour therapy compared with 
control significantly reduced weight in adults for up to three years and were associated 
with a WMD weight change in the range of 4 to 13 kg. Adding drugs, exercise or 
behaviour therapies to diet significantly reduced weight in adults for up to three years 
and were associated with a WMD weight change in the range of 1 to 8 kg. Adding one 
adjunct (either exercise or behaviour therapy) was effective but both in combination did 
not significantly improve weight loss. A 600 kcal/day deficit or low-fat diet; diet and 
exercise with and without behaviour therapy significantly reduced the risk of type 2 
diabetes and hypertension when compared with control. 
Diets alone and with the addition of exercise and/or behaviour therapy compared with 
control significantly prevented weight gain in adults for up to seven years and were 
associated with a WMD weight change in the range of 0.5 to 7 kg.  Compared to control, 
a 600 kcal/day deficit or low-fat diet; diet and exercise; diet and exercise and behaviour 
therapy; significantly reduced the risk of type 2 diabetes. Compared to control, a 600 
kcal/day deficit or low-fat diet; diet and exercise and behaviour therapy significantly 
reduced the risk of hypertension. Risk of the metabolic syndrome was significantly 
reduced with diet and exercise (in men); and with diet and exercise and behaviour 
therapy compared to control. Diet and behaviour therapy compared to control, 
significantly reduced the risk of ovarian cancer but not type 2 diabetes. 
Adding behaviour therapy to a prevention intervention produced greater weight loss 
compared with adding exercise. However exercise as an adjunct to diet is perhaps better 
in the longer term, as exercise, but not behaviour therapy, demonstrated significant 
weight loss when added to diet at three years. Meal replacements may be a useful tool in 
the long-term maintenance of weight loss. 
In the most recent and comprehensive review of school-based interventions for obesity 
prevention, 39% of interventions were effective in significantly improving mean BMI 
compared with control. Interventions which combined diet and physical activity had the 
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greatest percentage of effective studies compared with diet alone and physical activity 
alone.  
Lifestyle interventions can help prevent excessive weight gain in pregnancy and may 
help to reduce weight retention between pregnancies and prevent overweight in the 
offspring. Weight gain prevention interventions incorporated into smoking cessation 
programmes may help women who are concerned about their weight to stop smoking. 
Diet and exercise can help to reduce weight in post-menopausal women who are at 
increased risk of CVD. 
Currently there is more evidence of benefit from obesity treatment interventions 
compared with prevention interventions, from studies in adults compared with children 
and about short-term intermediary outcomes compared with longer-term clinical 
outcomes.  
Children and adults of ethnic minority status, low-income or disability are at increased 
risk of obesity. Evidence for effective interventions in these groups (with arguably the 
greatest need for intervention) is severely limited particularly from UK-based studies. 
There is also very limited evidence from interventions in pre-school children. It is 
unknown if and how interventions need to be modified in order to be targeted and 
tailored to the needs of these vulnerable groups.  
An important and under-researched area is lifestyle interventions for the treatment of 
morbid obesity. Demand for obesity surgery from adults that are morbidly obese is likely 
to outstrip resources in the UK, with 0.8% of all adults aged 16-24 years being morbidly 
obese12. A systematic review of diet, exercise and behaviour therapy interventions to 
treat morbid obesity is required to assess which adults are more likely to successfully 
lose weight without resorting to surgery.  
 
O2  to identify study characteristics, process indicators and contextual factors 
that may affect the outcomes of interventions 
There does not appear to be any clear pattern emerging from the data, in that both 
simple and complex interventions have demonstrated effectiveness. Longer-term, more 
intensive and theory-driven interventions have not always produced better results.  
Adults with CVD, hypertension or type 2 diabetes appear to lose more or less weight 
than participants without co-morbidities however the pattern is not consistent. There is 
limited evidence of lifestyle interventions to prevent weight gain in healthy normal weight 
adults within the community.  
With regard to prevention interventions in children; it is unclear what elements of 
interventions are consistently effective. Physical activity interventions appear more 
effective in girls in primary schools compared with boys and children in secondary 
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school. However, similar interventions were not tested across a range of ages and 
effectiveness could be due to the type of interventions used in this age group rather than 
the age itself. 
Most studies failed to report effectiveness stratified by demographic characteristics or 
information about process or contextual factors. More research is required into how and 
why study characteristics impact on effectiveness. 
Interventions may fail to show significant beneficial effect on weight because they are 
truly not effective or because methods of assessment and study design hamper 
evaluation of effectiveness.  Lack of evidence should not be confused with lack of 
effectiveness. In order to evaluate effectiveness it is crucial that the relevant research 
questions are asked and the relevant evidence is identified and evaluated in terms of the 
outcomes which best match the research questions.  
It is likely that the range and intensity of the components of an intervention, the duration 
of the intervention along with the type of setting and provider, all influence effectiveness. 
The demographics of the population in terms of age, gender, socio-economic status and 
ethnicity may all influence the effectiveness of an intervention as well as individual 
motivation to change behaviours. The aim of an intervention may also influence the 
outcome and in different ways, as demonstrated when comparing the reviews of children 
with the reviews of adults. The protocol of a systematic review influences which studies 
are included and how they are evaluated which impact on the overall assessment of 
effectiveness. Future evaluation of such effect modifiers will help towards producing 
optimal effective interventions including interventions modified for vulnerable 
subgroups68. 
Evidence shows there can be significant weight gain prevention in children from 
interventions not conceptualized as obesity prevention interventions which is opposite to 
evidence from interventions in adults which appear more successful when specifically 
aimed at weight loss.  
 
O3 to develop methodology to synthesize evidence from different study designs 
A more flexible approach to producing a systematic review is required when the purpose 
of the review is to develop guidance to help clinical practice or to help develop an 
intervention. In addition to effectiveness, public health decision makers require evidence 
of appropriateness, implementation, feasibility, acceptability and sustainability and the 
context of individual behaviour change within the wider community and socio-political 
environment.  
A „best available evidence‟ approach47 provides the flexibility to include more evidence 
which can be graded in terms of quality and relevance to the research question. 
Combining quantitative and qualitative evidence can add context, provide corroboration 
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and increase understanding, particularly with regard to complex public health 
interventions. Modeling future predictions of the potential impact of obesity interventions 
can provide justification to implement public health interventions even when the evidence 
from systematic reviews is limited.   
Developments in the methodology of searching and synthesizing evidence that have 
evolved within this submitted body of work have been applied in a recent systematic 
review69 conducted by the candidate. The aim of this review was to systematically review 
the effectiveness of diet and physical activity interventions to maintain a healthy weight 
and prevent overweight, that have been modified for South Asian pregnant women 
and/or children up to the age of 5 years, living in the UK.  
The search strategy included searching key systematic reviews; an electronic search to 
identify primary studies published after the NICE guidance on obesity37; a search of the 
„grey literature‟ and contact with experts. A stepped approach which included the „best 
available evidence‟ was applied in anticipation that there would be limited evidence from 
RCTs. All types of study design, including corroborative evidence, were included and the 
types of evidence prioritized by quality and relevance.  Each study was assessed 
according to the study outcome which best matched the primary aim of the study. 
Evidence from mainly uncontrolled studies showed a „direction of travel‟ towards 
beneficial behaviour change and corroborative evidence provided insight into what types 
of modifications have the potential to produce behaviour change in South Asian pregnant 
women and infants. Promising modifications to obesity prevention interventions include 
home-based elements; the use of experienced, respected and trusted community 
linkworkers; and harnessing the role of „significant others‟ such as grandmothers of 
South Asian children. 
The review highlighted the limited evidence of obesity prevention interventions modified 
for South Asian pregnant women and children under six years. The inclusion criteria was 
less stringent than the criteria for the NICE obesity reviews24 and so some evidence of 
direct relevance was identified but from weaker study designs.  
This review will inform the design and content of a series of projects as part of the Born 
in Bradford NHS Research Programme, which will be field tested to determine possible 
components of a culturally appropriate obesity-prevention intervention36;69.  
 
O4 to assess how the evidence has informed national strategies and clinical 
practice. 
The evidence contained within the submitted body of work underpins national guidance, 
informs government policy and influences clinical practice. 
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The NICE obesity guidance37 is underpinned by evidence contained within the NICE 
reviews24 of pre-school children; school-children; and black, minority ethnic groups, 
vulnerable groups and life stages. This evidence was also published as a short science 
review45 which informed the report on tackling obesity produced by Foresight the 
Government Office for Science18. The UK government obesity strategy and advertising 
campaign67 is in direct response to the NICE obesity guidance37 and future predictions 
contained within the Foresight report18.  
The Foresight report18 calls for a comprehensive, coherent and sustainable strategy to 
tackle obesity which requires a societal approach with partnership between government, 
science, business and civil society and intervention at multiple levels (individual, family, 
community and national). Any comprehensive long-term strategy to address obesity must 
include both prevention and treatment, with prevention being given priority. 
Early childhood provides an opportunity to influence lifestyle behaviours70 and promote a 
healthy lifestyle whilst simultaneously decreasing the risk of „high risk‟ behaviours 
becoming embedded and tracking through the lifespan. Therefore it would seem intuitive 
that service provision be targeted at pre-school children with ethnic minority children and 
children from low-income families receiving extra support through targeted and tailored 
intervention.   
There are proposals in recent media articles (Daily Mail, February 21st 2009) for children 
to be measured for weight at two years of age. This reflects the governments increasing 
focus on the early years as a crucial stage at which to combat obesity effectively. There 
is emerging evidence from ongoing trials in infants which will add to the evidence base in 
due course71.  
In response to the Foresight predictions and recommendations for change18 is the 
Change4Life campaign67. It is a society-wide movement underpinned by social marketing 
theory and techniques which aims to encourage change towards a healthier diet and 
increased physical activity. A review of interventions to „raise awareness‟ commissioned 
by NICE and conducted by the candidate demonstrated that public health media 
campaigns can raise awareness of what constitutes a healthy diet and the benefits of 
physical activity24. Dietary intake can improve, motivated subgroups can increase 
physical activity and food promotion has the potential to influence children‟s eating habits 
in a positive way. 
Change4Life67 targets pregnant women, parents of children aged 0-2 years, black and 
minority ethnic groups who have a higher than average BMI (starting with the 
Bangladeshi, Pakistani and Black African communities); and priority families that are at 
high risk of developing obesity and will require specific support.  
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The Change4Life marketing campaign is also based on qualitative research with families 
into attitudes and behaviours towards healthy eating and physical activity72. 
Change4Life67 targets eight behaviours: reducing sugar intake (“Sugar Swaps”), 
increasing consumption of fruit and vegetables (“5 A Day”), having structured meals, 
especially breakfast (“Meal Time”), reducing unhealthy snacking (“Snack Check”), 
reducing portion size (“Me Size Meals”), reducing fat consumption (“Cut Back Fat”), 60 
minutes of moderate intensity activity (“60 Active Minutes”) and reducing sedentary 
behaviour (“Up & About”). 
Through the Change4Life campaign67 the UK Department of Health is providing £30m to 
help nine towns to encourage healthy lifestyles73.  The nine areas taking part in the 
„Healthy Towns‟ Initiative are Manchester, Calderdale, Thetford, Portsmouth, Tower 
Hamlets, Dudley, Middlesbrough74, Tewkesbury and Sheffield. All these local initiatives 
are underpinned by national guidance37;37 which are based on the evidence from 
systematic reviews contained within this body of work. 
The governments‟ obesity strategy is based on the „best available‟ evidence and both the 
NICE obesity guidance37 and Foresight obesity report18 underpin evidence-based clinical 
practice for weight management in individuals and local obesity strategies. Tackling 
obesity is a priority for primary care trusts (PCTs) and there is a national goal to reduce 
the proportion of obese and overweight children to 2000 levels by 2020, as set out in 
Healthy Weight, Healthy Lives: A cross-government strategy for England75.  
The candidate has recently produced a rapid needs assessment of childhood healthy 
weight, commissioned by NHS Knowsley76. The approach was underpinned by best 
practice guidance in section C of Healthy Weight, Healthy Lives: A toolkit for developing 
local strategies77. The needs assessment examined local prevalence of overweight and 
applied national targets to the data in order to assess whether current service provision 
had adequate capacity to manage current and future levels of obesity.  
It may be more difficult to produce change on a population-wide scale. The Foresight 
report18 built on the evidence-base by modeling future levels of obesity to predict that by 
2050, 60% of men, 50% of women and 25% of children will be obese, with obesity-
related diseases costing an additional £45.5 billion per year. Modeling of the impact of 
various intervention scenarios demonstrated that significant changes in population BMI 
(a reduction of four BMI units across the whole population) will be required to produce 
significant changes in chronic disease levels, taking into account obesity across the 
lifespan and a considerable time-lag between reduction in BMI and improvement in 
obesity-related disease. 
There are no rigorously tested population-wide interventions to prevent or treat obesity 
and strategies may have to rely more on the potential that interventions contained within 
this body of work have demonstrated.  Population-wide interventions may suffer from a 
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perceived lack of need or motivation to change behaviour. From an individual 
perspective; the costs of positive energy balance are in the distant future and not as 
potent (and so not as readily amenable to change) as the immediate experienced 
„benefit‟ of leading a sedentary lifestyle with an energy-dense diet that is currently 
supported by the immediate environment78.  
A comprehensive, systematic and sustainable public healthy obesity prevention strategy 
is beginning to come into force which is underpinned by the best available evidence 
contained within this submitted body of work. Whilst both prevention and treatment are 
necessary to manage obesity; the priority of any comprehensive strategy should be 
prevention by behavioural change; beginning at the stage of pre-conception. Population-
wide recommendations may be effective in preventing a population increase in the 
prevalence of obesity only as part of a government strategy that includes environmental 
change and is coupled with targeted interventions to reduce the prevalence of obesity 
caused at least in part by social inequalities. 
 
4.2 Practice recommendations  
4.2.1 Recommendations for reviewers producing systematic reviews 
of obesity interventions  
1. In cases where it is anticipated that limited evidence will be identified from high 
quality intervention studies; a „stepped approach‟ using the „best available 
evidence‟ is recommended. Rather than attempt to pre-specify which types of 
study design will be included it is more constructive to include a wide range of 
study designs (at least initially) and prioritize each identified intervention 
according to quality and relevance to the research question. Adopting this 
approach will influence each element of the process of producing a review 
including protocol, search strategy, inclusion criteria, data extraction and analysis.  
2. The aims and objectives of a review should include clear and concise research 
questions to guide the reviewer when searching, extracting, synthesizing and 
analysing data. The results of the review should answer the research questions 
and describe the strength of the evidence underpinning the answers and, if 
necessary, give reasons why research questions cannot be answered. 
3. It is important that the reviewer clearly states which outcomes will be used to 
determine whether an intervention is „successful‟ (e.g. significant beneficial 
change in BMI or prevalence of overweight or both?)  
4. The protocol needs to reflect the iterative nature of conducting a systematic 
review of complex public health interventions and allow for flexibility. 
5. Inclusion criteria and search strategies need to be broad (because some 
evidence of direct relevance to the research question may be identified from 
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weaker study designs). A wide range of sources of evidence should be searched 
to identify the „best available evidence‟. These include but are not limited to: 
● electronic databases (e.g. MEDLINE, EMBASE, Cochrane)  
 ● systematic reviews  
● websites (e.g. HTA, NICE, Medical Research Council, Food Standards  
Agency, Health Management Information Consortium, Evidence for Policy and 
Practice Information and Coordinating Centre)  
● research registries (e.g. National Research Register)  
● research networks  
● databases of PhDs (e.g. British Library and Index to Theses) 
● journals and conference proceedings  
● reference lists of included interventions and systematic reviews  
● experts (e.g. academics, dietitians, community linkworkers, key people active in 
local government and primary care trusts). 
6. Outcome data should be extracted for mean BMI and prevalence of overweight. 
BMI is a useful measure to assess obesity from a public health perspective 
however prevalence data is equally important because it may be more sensitive 
to changes within individuals and vulnerable subgroups; which is useful 
information for policy-makers. 
7. Process data should be extracted including data on appropriateness, 
implementation, feasibility, acceptability, sustainability and context. Evaluation of 
environmental change within which behaviour change occurs is vital. Both 
outcome and process data should be viewed as equally important elements of 
any intervention. 
8. It is useful to map the intervention according to the spheres of influence that each 
intervention aims to influence (e.g. individual, family, school, supermarket, leisure 
facility). Mapping will produce a clear picture of where evidence is relatively 
„strong‟, where there are gaps which require further research, and whether 
effectiveness varies according to the spheres of influence of the intervention. 
9. The „best available evidence‟ needs to be synthesized in order to make sense of 
the evidence. This can be done by grading the evidence according to quality and 
relevance to the research question. This provides the end-user with a certain 
level of confidence in the evidence which underpins the answers to the research 
questions. 
 
4.2.2 Recommendations for researchers carrying out primary 
interventions in obesity research 
Many practice recommendations for systematic reviewers (4.3.1) are useful to primary 
researchers when reporting their study. In addition, comprehensive and systematic 
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measurement of BMI during childhood throughout the UK using one universal method of 
classification of overweight would greatly enhance the work of these researchers. 
1. Systematic reviews of the „best available evidence‟ should be used to inform 
primary research. Primary studies should test interventions which show the 
greatest potential for health benefit (e.g. combined diet and physical activity 
interventions in schools) rather than interventions which evidence shows are 
unlikely to be effective (e.g. nutrition education alone). This will increase the 
likelihood of identifying an effective intervention and increase the evidence base. 
2. Studies are needed which repeat interventions across the age range which have 
already shown potential for effectiveness in children, to evaluate whether it is the 
nature of the intervention or the age of the child which influences the effect. 
3. More community-based interventions are required to reflect real life and 
recognition of the influence of an obesogenic environment. There is currently 
limited evidence of lifestyle interventions to prevent weight gain in healthy normal 
weight adults within the community. Many new policy interventions are 
community-based and we need to build an evidence-base of such interventions 
and develop new methods of evaluation. 
4. Studies are required which are targeted and tailored for vulnerable groups at 
increased risk of obesity (e.g. minority ethnic groups, low-income groups and 
groups with limiting disabilities) and vulnerable life-stages (e.g. pregnancy and 
menopause).  
5. Studies need to be sufficiently powered and of long enough duration to detect 
significant differences in outcome measures. 
6. Study protocols should be registered to increase dissemination and reduce 
publication bias. Registration of protocols would also allow reviewers to assess 
whether outcomes that researchers aimed to measure were measured and 
reported (this is now recognised as an important element of quality assessment). 
7. The aim of the study, the intervention and the primary outcomes of interest 
should be explicitly stated and justified. The intervention and the outcomes 
measured should match the aim (e.g. do interventions which increase fruit intake 
or provide a healthy breakfast at school „fit‟ with an aim of preventing excessive 
obesity and is this best measured by behaviour change and/or weight change?) 
8. A detailed description of the intervention including range, intensity, who when and 
how it was carried out should be reported. 
9. Detailed reporting of demographic characteristics such as age, gender, socio-
economic status and ethnicity is needed in order for reviewers to measure the 
impact of these variables on effectiveness and the impact of the intervention on 
health inequalities. 
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10. Change in mean BMI and prevalence of overweight should both be measured as 
it is useful to assess how change in prevalence and mean BMI has occurred (e.g. 
is prevalence change due to weight loss in the overweight population or is 
reduction in mean BMI due to reduced incidence in the normal weight 
population?)  
11. The number of participants assessed at each time point in each group and the 
mean and standard deviation change for each outcome needs to be reported in 
order for systematic reviewers to carry out meta-analyses. 
12. Process data should be measured and reported including data on 
appropriateness, implementation, feasibility, acceptability, sustainability and 
context. 
13. Costs relating to carrying out the intervention should be measured and reported. 
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